Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYO9B AK9 MYO3A CHD6 ABCD2 RAD51 KIF23 DNAH10 HSPA4L LONP2 DYNC2H1 DHX37 SMARCAL1 DNAH7 MLH3 ABCA5 AACS ERCC6L2 KIF13A TOP2A DNAH11	7.28e-07	614	196	21	GO:0140657
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MYO9B LRRK2 AK9 RASL12 SEPTIN6 CHD6 ABCD2 RAD51 KIF23 DNAH10 LONP2 DYNC2H1 RGS5 DHX37 ARL13A DNAH7 MLH3 ABCA5 DNM3 KIF13A GFM1 MMUT DNAH11	2.38e-06	775	196	23	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	MYO9B LRRK2 AK9 RASL12 SEPTIN6 CHD6 ABCD2 RAD51 KIF23 DNAH10 CILP LONP2 DYNC2H1 RGS5 DHX37 ARL13A DNAH7 MLH3 ABCA5 DNM3 KIF13A GFM1 MMUT DNAH11	2.67e-06	839	196	24	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	MYO9B LRRK2 AK9 RASL12 SEPTIN6 CHD6 ABCD2 RAD51 KIF23 DNAH10 CILP LONP2 DYNC2H1 RGS5 DHX37 ARL13A DNAH7 MLH3 ABCA5 DNM3 KIF13A GFM1 MMUT DNAH11	2.73e-06	840	196	24	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	MYO9B LRRK2 AK9 RASL12 SEPTIN6 CHD6 ABCD2 RAD51 KIF23 DNAH10 CILP LONP2 DYNC2H1 RGS5 DHX37 ARL13A DNAH7 MLH3 ABCA5 DNM3 KIF13A GFM1 MMUT DNAH11	2.73e-06	840	196	24	GO:0016818
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 DYNC2H1 DNAH7 CCDC88C DNAH11	7.08e-06	28	196	5	GO:0051959
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO9B MYO3A KIF23 DNAH10 DYNC2H1 DNAH7 KIF13A DNAH11	2.17e-05	118	196	8	GO:0003774
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DYNC2H1 DNAH7 DNAH11	2.47e-05	18	196	4	GO:0008569
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYO9B AK9 CHD6 ABCD2 RAD51 KIF23 DNAH10 LONP2 DYNC2H1 DHX37 DNAH7 MLH3 ABCA5 KIF13A DNAH11	3.20e-05	441	196	15	GO:0016887
GeneOntologyMolecularFunction	microtubule motor activity	KIF23 DNAH10 DYNC2H1 DNAH7 KIF13A DNAH11	6.45e-05	70	196	6	GO:0003777
GeneOntologyMolecularFunction	lipopeptide binding	TLR6 CD1D TLR1	1.06e-04	10	196	3	GO:0071723
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH10 DYNC2H1 DNAH7 DNAH11	4.61e-04	37	196	4	GO:0045505
GeneOntologyMolecularFunction	Toll-like receptor 2 binding	TLR6 TLR1	5.68e-04	4	196	2	GO:0035663
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	EPRS1 CMTR1 LRRC47 CHD6 NIPBL REV1 RAD51 TUT4 DHX37 SMARCAL1 POLR2A MRM3 MLH3 ERCC6L2 PRORP TOP2A	6.52e-04	645	196	16	GO:0140640
Domain	P-loop_NTPase	SAMD9 MYO9B LRRK2 AK9 RASL12 SEPTIN6 MYO3A CHD6 ABCD2 GNL3 RAD51 KIF23 GNL3L DNAH10 LONP2 DYNC2H1 DHX37 SMARCAL1 ARL13A DNAH7 SBNO2 NLRP14 ABCA5 SBNO1 ERCC6L2 DNM3 KIF13A GFM1 DNAH11	1.96e-08	848	196	29	IPR027417
Domain	-	SAMD9 LRRK2 AK9 RASL12 SEPTIN6 CHD6 ABCD2 GNL3 RAD51 GNL3L DNAH10 LONP2 DYNC2H1 DHX37 SMARCAL1 ARL13A DNAH7 SBNO2 NLRP14 ABCA5 SBNO1 ERCC6L2 DNM3 GFM1 DNAH11	3.01e-07	746	196	25	3.40.50.300
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DYNC2H1 DNAH7 DNAH11	1.08e-05	14	196	4	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DYNC2H1 DNAH7 DNAH11	1.08e-05	14	196	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DYNC2H1 DNAH7 DNAH11	1.08e-05	14	196	4	IPR013602
Domain	DHC_N2	DNAH10 DYNC2H1 DNAH7 DNAH11	1.08e-05	14	196	4	PF08393
Domain	MT	DNAH10 DYNC2H1 DNAH7 DNAH11	1.08e-05	14	196	4	PF12777
Domain	AAA_8	DNAH10 DYNC2H1 DNAH7 DNAH11	1.08e-05	14	196	4	PF12780
Domain	DHC_fam	DNAH10 DYNC2H1 DNAH7 DNAH11	1.47e-05	15	196	4	IPR026983
Domain	Dynein_heavy	DNAH10 DYNC2H1 DNAH7 DNAH11	1.47e-05	15	196	4	PF03028
Domain	Dynein_heavy_dom	DNAH10 DYNC2H1 DNAH7 DNAH11	1.47e-05	15	196	4	IPR004273
Domain	AAA	AK9 ABCD2 RAD51 DNAH10 LONP2 DYNC2H1 DNAH7 ABCA5 DNAH11	2.16e-05	144	196	9	SM00382
Domain	AAA+_ATPase	AK9 ABCD2 RAD51 DNAH10 LONP2 DYNC2H1 DNAH7 ABCA5 DNAH11	2.16e-05	144	196	9	IPR003593
Domain	-	LONP2 MLH3 GFM1 TOP2A	6.12e-05	21	196	4	3.30.230.10
Domain	DHC_N1	DNAH10 DYNC2H1 DNAH11	6.13e-05	8	196	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH10 DYNC2H1 DNAH11	6.13e-05	8	196	3	IPR013594
Domain	Ribosomal_S5_D2-typ_fold_subgr	LONP2 MLH3 GFM1 TOP2A	7.42e-05	22	196	4	IPR014721
Domain	SNO	SBNO2 SBNO1	1.10e-04	2	196	2	IPR026741
Domain	SBNO_Helicase_C_dom	SBNO2 SBNO1	1.10e-04	2	196	2	IPR026937
Domain	Helicase_C_4	SBNO2 SBNO1	1.10e-04	2	196	2	PF13871
Domain	ATPase_dyneun-rel_AAA	DNAH10 DYNC2H1 DNAH11	3.80e-04	14	196	3	IPR011704
Domain	AAA_5	DNAH10 DYNC2H1 DNAH11	3.80e-04	14	196	3	PF07728
Domain	Ribosomal_S5_D2-typ_fold	LONP2 MLH3 GFM1 TOP2A	4.26e-04	34	196	4	IPR020568
Domain	EF-hand_like	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	PF09279
Domain	PI-PLC-Y	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	PF00387
Domain	PLCYc	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	PS50008
Domain	PI-PLC_fam	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	IPR001192
Domain	PLC_EF-hand-like	PLCL2 PLCB2 PLCG2	4.72e-04	15	196	3	IPR015359
Domain	HIN_200	PYHIN1 IFI16	6.48e-04	4	196	2	PS50834
Domain	HIN	PYHIN1 IFI16	6.48e-04	4	196	2	PF02760
Domain	HIN200/IF120x	PYHIN1 IFI16	6.48e-04	4	196	2	IPR004021
Domain	PI-PLC-X	PLCL2 PLCB2 PLCG2	8.27e-04	18	196	3	PF00388
Domain	PLCXc	PLCL2 PLCB2 PLCG2	8.27e-04	18	196	3	SM00148
Domain	PIPLC_X_DOMAIN	PLCL2 PLCB2 PLCG2	9.74e-04	19	196	3	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCL2 PLCB2 PLCG2	9.74e-04	19	196	3	IPR000909
Domain	Toll-like_receptor	TLR6 TLR1	1.07e-03	5	196	2	IPR017241
Domain	-	SACS MLH3 TOP2A	1.14e-03	20	196	3	3.30.565.10
Domain	HATPase_C	SACS MLH3 TOP2A	1.32e-03	21	196	3	IPR003594
Domain	DAPIN	PYHIN1 IFI16 NLRP14	1.51e-03	22	196	3	PS50824
Domain	PYRIN	PYHIN1 IFI16 NLRP14	1.51e-03	22	196	3	SM01289
Domain	PYRIN	PYHIN1 IFI16 NLRP14	1.51e-03	22	196	3	PF02758
Domain	DAPIN	PYHIN1 IFI16 NLRP14	1.51e-03	22	196	3	IPR004020
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	EPRS1 ATR TRIO VPS13C CORO1C RTN3 NOL10 CMYA5 SPDL1 LRRC47 PYCR1 UTP20 NIPBL GNL3 MYBBP1A KIF23 GNL3L DNAH10 HSPA4L DYNC2H1 DNAJC8 NSD2 DHX37 U2SURP POLR2A GEMIN5 APOB CBS LARP7 MRM3 SBNO1 GFM1 TOP2A	1.22e-11	1425	202	33	30948266
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EPRS1 ATR CDK12 ADD1 PPIG MYO3A IQSEC1 UTP20 NIPBL MYBBP1A KIF23 ARID4A ARGLU1 POLR2A GEMIN5 NSMCE3 IFI16 ZNF106 BRD2 SLC4A1AP LMO7 PHF3 TPX2 TOP2A	3.06e-11	774	202	24	15302935
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD EPRS1 TRIO CORO1C CMYA5 UBASH3A SACS CHD6 NIPBL VWF ANK2 KALRN ARGLU1 VPS39 ATP5MF ZFC3H1 CBS KRIT1 ZNF34 BRD2 SBNO1 LMO7 MICAL2 DNM3 TMEM131 CCN2 RSBN1L EXOC4	2.00e-09	1285	202	28	35914814
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	EPRS1 MYO9B CORO1C NOL10 LRRC47 WASHC5 IQSEC1 PYCR1 UTP20 PLCG2 NIPBL ALOX12B GNL3 MYBBP1A KIF23 GNL3L DHX37 U2SURP POLR2A GEMIN5 IFI16 MICAL2 SBDS TXNDC9 ZNF281 TOP2A AHNAK2 EXOC4	6.13e-09	1353	202	28	29467282
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CORO1C AK9 DIAPH2 GNL3L HSPA4L DHX37 U2SURP POLR2A APOA2 ZNF106 NDUFAF4 RNFT2 SLC4A1AP LMO7 ERCC6L2 RP1 RSBN1L	6.36e-09	497	202	17	36774506
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	EPRS1 CDK12 NOL10 TRIM24 NIPBL GNL3 MYBBP1A KIF23 ARID4A DNAJC8 ARGLU1 NSD2 U2SURP POLR2A NSMCE3 BRD2 SLC4A1AP PHF3 TPX2 ZNF281 TOP2A RSBN1L INO80B	9.87e-09	954	202	23	36373674
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L EPRS1 SAMD9 ATR CDK12 WASHC5 GORASP1 DIAPH2 GAPDHS GNL3L LONP2 DHX37 ATP5MF SBNO2 ARFGAP2 LLGL2 AACS RSBN1L EXOC4	1.01e-08	650	202	19	38777146
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EPRS1 CDK12 CORO1C ADD1 SPDL1 MYBBP1A KIF23 DNAJC8 POLR2A GEMIN5 LMO7 PHF3 TET1 TPX2 TOP2A RSBN1L EXOC4	2.72e-08	549	202	17	38280479
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ATR CDK12 PPIG NIPBL GNL3 MYBBP1A KIF23 DNAJC8 ARGLU1 GLRX3 NSD2 SMARCAL1 POLR2A GEMIN5 NSMCE3 IFI16 LARP7 BRD2 SBNO1 PHF3 SBDS TPX2 TOP2A	3.02e-08	1014	202	23	32416067
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SECISBP2L EPRS1 CDK12 NOL10 SEPTIN6 ADD1 LRRC47 NGRN PPIG LARP4B IQSEC1 PYCR1 CCDC106 GNL3 MYBBP1A GNL3L ANK2 DHX37 SMARCAL1 APOB LARP7 MRM3 LMO7 PHF3 EPHA2 TPX2 RSBN1L	3.26e-08	1371	202	27	36244648
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EPRS1 CDK12 LARP4B NIPBL MYBBP1A KIF23 KALRN GEMIN5 IFI16 LMO7 PHF3 TPX2 TMEM131 KIF13A TOP2A EXOC4	4.91e-08	503	202	16	16964243
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TRIO CDK12 VPS13C CORO1C ADD1 SPDL1 LARP4B CHD6 GNL3 KIF23 TUT4 GNL3L POLR2A ZNF106 PHF3 TPX2 TMEM131 GFM1 RSBN1L	6.71e-08	733	202	19	34672954
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	TRIM24 IQSEC1 NIPBL REV1 KIF23 ZFC3H1 ZNF106 MLH3 BRD2 TPX2 ZNF281	8.36e-08	222	202	11	37071664
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	VPS13C BPIFB1 TRIM24 SEPTIN6 PYCR1 CHD6 PLCG2 TUT4 DYNC2H1 DNAJC8 VPS39 DHX37 POLR2A APOB ESYT3 ARFGAP2 TPX2 KIF13A EXOC4	1.04e-07	754	202	19	35906200
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	TRIM24 FSIP2 CHD6 NIPBL GNL3 KIF23 GNL3L ARID4A NSD2 DHX37 BRD2 SBNO1 SLC4A1AP PHF3 TPX2 ZNF281 TOP2A	1.17e-07	608	202	17	36089195
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CDK12 CORO1C NOL10 LARP4B UTP20 CHD6 NIPBL GNL3 GNL3L LONP2 DNAJC8 ARGLU1 NSD2 POLR2A GEMIN5 ATP5MF ZFC3H1 LARP7 MRM3 SLC9A1 BRD2 SLC4A1AP PHF3 TPX2 ZNF281 RSBN1L INO80B	1.91e-07	1497	202	27	31527615
Pubmed	UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.	CORO1C AK9 PPIG PYCR1 GNL3 MYBBP1A KIF23 GNL3L DYNC2H1 DNAJC8 ARGLU1 U2SURP ATP5MF APOB SBDS	2.19e-07	491	202	15	36273042
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	ATR CORO1C NOL10 ADD1 PPIG RAD51 NSD2 DHX37 POLR2A KRIT1 ARFGAP2 PHF3 FYB1	3.00e-07	370	202	13	22922362
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	EPRS1 CORO1C SPDL1 MYBBP1A KIF23 POLR2A GEMIN5 LMO7 EPHA2 TPX2 AHNAK2	3.49e-07	256	202	11	33397691
Pubmed	ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.	CORO1C GAPDHS GNL3 MYBBP1A LMO7 EPHA2	4.58e-07	50	202	6	37001908
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	EPRS1 ATR NOL10 PPIG UTP20 CHD6 NIPBL GNL3 MYBBP1A KIF23 ARID4A ARGLU1 NSD2 U2SURP POLR2A ZFC3H1 IFI16 ZNF106 BRD2 LMO7 PHF3 TPX2 ZNF281 TOP2A	5.93e-07	1294	202	24	30804502
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD BPIFB1 MDM2 TRIM24 LARP4B IQSEC1 GNL3 ARAP2 TUT4 GNL3L ARGLU1 NSD2 FAT3 POLR2A L1TD1 LARP7 MLH3 BRD2 ZNF281 TOP2A RSBN1L INO80B	6.65e-07	1116	202	22	31753913
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CYLD TRIO VPS13C CORO1C SEPTIN6 PPIG WASHC5 CPLANE1 GNL3 CCDC14 DHX37 CEP192 DNAH7 CCDC88C ARFGAP2 TMEM131 TOP2A VPS29 EXOC4	6.74e-07	853	202	19	28718761
Pubmed	GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.	MDM2 GNL3 GNL3L	7.69e-07	4	202	3	21132010
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD TRIO FSIP2 IQSEC1 ARAP2 KIF23 SASH1 CEP192 PTPN21 DNAH7 CCDC88C ZNF106 ARFGAP2 LMO7 PHF3 TET1 KIF13A AHNAK2 EXOC4	7.75e-07	861	202	19	36931259
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	ATR UTP20 NIPBL GNL3 GNL3L LONP2 VPS39 SMARCAL1 IFI16 ZNF106 ARFGAP2 TPX2 DNM3	9.51e-07	410	202	13	26949251
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	EPRS1 TRIO CORO1C RTN3 SEPTIN6 ADD1 LRRC47 CPNE6 SACS WASHC5 NTM IQSEC1 MYBBP1A VWF ANK2 KALRN HSPA4L ARGLU1 GEMIN5 ATP5MF LMO7 MICAL2 CACNA2D3 EXOC4 DNAH11	1.01e-06	1431	202	25	37142655
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH10 DYNC2H1 DNAH7 DNAH11	1.06e-06	14	202	4	9373155
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	EPRS1 SAMD9 CORO1C NOL10 ADD1 LRRC47 LARP4B UTP20 GAPDHS GNL3 MYBBP1A KIF23 GNL3L ARGLU1 DHX37 ATP5MF ZFC3H1 IFI16 LMO7 PHF3 TPX2 TOP2A RSBN1L	1.30e-06	1257	202	23	36526897
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CYLD CMTR1 ADD1 LARP4B TUT4 DHX37 GEMIN5 ZFC3H1 NSMCE3 LMO7 PHF3 SBDS EPHA2 TMEM131 ZNF281 AHNAK2 EXOC4	1.32e-06	724	202	17	36232890
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CYLD CMTR1 CORO1C LRRC47 CHD6 CCDC14 KIF23 GNL3L ARID4A NSD2 POLR2A LARP7 BRD2 TPX2 TXNDC9 EXOC4	1.35e-06	645	202	16	25281560
Pubmed	Nucleostemin prevents telomere damage by promoting PML-IV recruitment to SUMOylated TRF1.	GNL3 RAD51 GNL3L	1.91e-06	5	202	3	22641345
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CYLD RTN3 TRIM24 ADD1 LRRC47 SACS PYCR1 GNL3 MYBBP1A ANK2 HSPA4L DYNC2H1 DNAJC8 ARGLU1 CEP192 ZFC3H1 LARP7 NDUFAF4 BRD2 SLC4A1AP EPHA2 LRRC1 TMEM131 FAM177A1 EXOC4	2.00e-06	1487	202	25	33957083
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MYO9B CDK12 NOL10 LARP4B UTP20 GNL3 MYBBP1A KIF23 NSD2 DHX37 ZFC3H1 LARP7 MRM3 PHF3 TPX2 TOP2A EXOC4	2.48e-06	759	202	17	35915203
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPRS1 CDK12 ADD1 NIPBL GNL3 MYBBP1A KIF23 GNL3L ANK2 U2SURP POLR2A GEMIN5 CBS TPX2 TXNDC9 ZNF281 TOP2A RSBN1L AHNAK2	2.55e-06	934	202	19	33916271
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	EPRS1 CORO1C NOL10 WASHC5 UTP20 MYBBP1A KIF23 GNL3L DHX37 U2SURP ZFC3H1 IFI16 LARP7 LMO7 PHF3 TPX2 TOP2A INO80B	2.59e-06	847	202	18	35850772
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CDK12 MAPKAPK2 CDK19 PPIG LARP4B CLIC5 GNL3 MYBBP1A DNAJC8 ARGLU1 LARP7 SLC4A1AP PHF3 LRRC1 ZNF281 EPHA3	3.50e-06	695	202	16	23602568
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	EPRS1 MYO9B CORO1C ADD1 LRRC47 PPIG GNL3 RAD51 MYBBP1A KIF23 HSPA4L ARGLU1 U2SURP POLR2A LARP7 LMO7 MICAL2 PHF3 WDR87 EPHA2 ZNF281 TOP2A	4.03e-06	1247	202	22	27684187
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	MDM2 NIPBL REV1 RAD51 NSD2 SMARCAL1 NSMCE3 LMO7	4.11e-06	157	202	8	30686591
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	NOL10 ADD1 LARP4B UTP20 GNL3 KIF23 NSD2 POLR2A IFI16 LARP7 TOP2A	4.37e-06	332	202	11	25693804
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	MYO9B CDK12 MDM2 ADAM28 ERVK-25 CPLANE1 REV1 VWF KALRN POLR2A ESYT3 LMO7 CACNA2D3 DNAH11	4.89e-06	552	202	14	10737800
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	EPRS1 ATR ADD1 WASHC5 NIPBL SMARCAL1 U2SURP GEMIN5 LMO7 TPX2 TOP2A	5.48e-06	340	202	11	24332808
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	CORO1C BPIFB1 NOL10 LRRC47 UTP20 GNL3 MYBBP1A DHX37 U2SURP LARP7 MRM3 TOP2A RSBN1L	5.70e-06	483	202	13	36912080
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CORO1C NOL10 PYCR1 UTP20 GNL3 MYBBP1A KIF23 GNL3L DHX37 U2SURP POLR2A ZNF106 BRD2 SLC4A1AP PHF3 TPX2 GFM1 TOP2A RSBN1L	5.79e-06	989	202	19	36424410
Pubmed	A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.	MYBBP1A NSD2 GEMIN5 CCDC88C	6.12e-06	21	202	4	24923560
Pubmed	Aire's partners in the molecular control of immunological tolerance.	CHD6 MYBBP1A POLR2A GEMIN5 TOP2A	6.36e-06	45	202	5	20085707
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NOL10 LRRC47 LARP4B UTP20 NIPBL GNL3 MYBBP1A KIF23 NSD2 DHX37 U2SURP POLR2A GEMIN5 LARP7 PHF3	7.32e-06	653	202	15	22586326
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD CDK12 CDK19 CHD6 VPS39 LMO7 PHF3 DNM3 POFUT1	7.40e-06	225	202	9	12168954
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ATR CDK12 LRRC47 MED12L NIPBL MYBBP1A ARGLU1 U2SURP BRD2 LMO7 LRRC1 TPX2 TOP2A EXOC4	8.89e-06	582	202	14	20467437
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	EPRS1 CDK12 CORO1C ADD1 SPDL1 WASHC5 DNAJC8 U2SURP LARP7 SLC4A1AP LMO7 PHF3 TPX2	9.36e-06	506	202	13	30890647
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	NIPBL MYBBP1A NSD2 PHF3 TPX2 TOP2A	1.14e-05	86	202	6	37253089
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	EPRS1 CORO1C NOL10 LRRC47 UTP20 GNL3 MYBBP1A KIF23 GNL3L ARGLU1 DHX37 U2SURP APOB IFI16 LLGL2 LMO7 TPX2 TOP2A	1.22e-05	949	202	18	36574265
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ATR CDK19 RAD51 KIF23 ZFC3H1 NSMCE3 IFI16 ZNF106 SLC4A1AP PHF3 TPX2 ZNF281	1.54e-05	453	202	12	29656893
Pubmed	The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.	ATR RAD51 ISCA1 POLR2A CBS MRM3 MMUT	2.25e-05	144	202	7	30585266
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	SAMD9 CMTR1 TRIO CDK12 NOL10 SPDL1 KIF23 DNAJC8 POLR2A SLC4A1AP PHF3 TXNDC9	2.30e-05	472	202	12	38943005
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRIO MYO9B CDK12 MAPKAPK2 PLEKHM1 DIAPH2 RAD51 KALRN VPS39 NSD2 POLR2A GEMIN5 CEP192 SBNO2 CCDC88C LLGL2 BRD2 POFUT1 AHNAK2	2.69e-05	1105	202	19	35748872
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	EPRS1 NIPBL KIF23 POLR2A GEMIN5 LMO7 PHF3 TPX2 TOP2A AHNAK2	2.71e-05	332	202	10	32786267
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	EPRS1 NOL10 ADD1 PPIG WASHC5 IQSEC1 PYCR1 CHD6 NIPBL GNL3 MYBBP1A HSPA4L ARGLU1 DHX37 U2SURP GEMIN5 ATP5MF LARP7 TXNDC9 TOP2A RSBN1L	3.06e-05	1318	202	21	30463901
Pubmed	Directed proteomic analysis of the human nucleolus.	ATR NOL10 UTP20 GNL3 MYBBP1A DNAJC8 RP1 TOP2A	3.17e-05	208	202	8	11790298
Pubmed	Human transcription factor protein interaction networks.	CYLD CORO1C MDM2 TRIM24 SEPTIN6 LARP4B CHD6 NIPBL GNL3 SENP5 MYBBP1A KIF23 DNAH10 ARID4A HSPA4L DHX37 CEP192 BRD2 TPX2 ZNF281 INO80B EXOC4	3.29e-05	1429	202	22	35140242
Pubmed	LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.	LRRK2 EXOC4	3.36e-05	2	202	2	33498474
Pubmed	Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis.	PF4 PPBP	3.36e-05	2	202	2	25858640
Pubmed	Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6.	TLR6 TLR1	3.36e-05	2	202	2	22315281
Pubmed	The Guanine nucleotide exchange factor kalirin-7 is a novel synphilin-1 interacting protein and modifies synphilin-1 aggregate transport and formation.	KALRN SNCAIP	3.36e-05	2	202	2	23284848
Pubmed	Scatter factor/hepatocyte growth factor is essential for liver development.	HGF VWF	3.36e-05	2	202	2	7854452
Pubmed	[DISTRIBUTION OF TWO-LOCUS HAPLOTYPES OF MICROBIAL COMPONENT SENSOR GENES TLR1 AND TLR6 IN MAJOR POPULATIONS OF SOUTH URALS].	TLR6 TLR1	3.36e-05	2	202	2	26470427
Pubmed	Increased concentration of platelet-derived chemokines in serum of patients with delayed pressure urticaria.	PF4 PPBP	3.36e-05	2	202	2	18632422
Pubmed	Expression of a novel TGIF subclass homeobox gene, Tex1, in the spermatids of mouse testis during spermatogenesis.	TGIF2LY TGIF2LX	3.36e-05	2	202	2	11960710
Pubmed	Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.	TLR6 TLR1	3.36e-05	2	202	2	21852947
Pubmed	Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.	MDM2 GNL3	3.36e-05	2	202	2	22318725
Pubmed	Proteomic analysis reveals platelet factor 4 and beta-thromboglobulin as prognostic markers in severe acute respiratory syndrome.	PF4 PPBP	3.36e-05	2	202	2	22740477
Pubmed	ATR phosphorylates SMARCAL1 to prevent replication fork collapse.	ATR SMARCAL1	3.36e-05	2	202	2	23873943
Pubmed	Comprehensive genetic study of fatty acids helps explain the role of noncoding inflammatory bowel disease associated SNPs and fatty acid metabolism in disease pathogenesis.	LRRK2 CBS	3.36e-05	2	202	2	29549916
Pubmed	Ratio of Apolipoprotein A-II/B Improves Risk Prediction of Postoperative Survival After Carotid Endarterectomy.	APOA2 APOB	3.36e-05	2	202	2	25953375
Pubmed	Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.	TLR6 TLR1	3.36e-05	2	202	2	11123271
Pubmed	Genetic ancestry effects on the distribution of toll-like receptors (TLRs) gene polymorphisms in a population of the Atlantic Forest, São Paulo, Brazil.	TLR6 TLR1	3.36e-05	2	202	2	29175392
Pubmed	Connective tissue growth factor is a substrate of ADAM28.	ADAM28 CCN2	3.36e-05	2	202	2	20971063
Pubmed	Toll-like receptor 6 and connective tissue growth factor are significantly upregulated in mitomycin-C-treated urothelial carcinoma cells under hydrostatic pressure stimulation.	TLR6 CCN2	3.36e-05	2	202	2	24689870
Pubmed	The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.	TLR6 TLR1	3.36e-05	2	202	2	28474755
Pubmed	DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.	LRRK2 DNM3	3.36e-05	2	202	2	27692902
Pubmed	Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.	EPHA2 EPHA3	3.36e-05	2	202	2	29945963
Pubmed	[RAD51 regulates REV1 recruitment to DNA double-strand <br/>break sites].	REV1 RAD51	3.36e-05	2	202	2	30465533
Pubmed	Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.	TRIO KALRN	3.36e-05	2	202	2	26858404
Pubmed	Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.	TLR6 TLR1	3.36e-05	2	202	2	18036178
Pubmed	Intracellular calcium dynamics in cortical microglia responding to focal laser injury in the PC::G5-tdT reporter mouse.	AIF1 POLR2A	3.36e-05	2	202	2	26005403
Pubmed	An Evaluation of Platelet Factor 4, Beta-Thromboglobulin and Mean Platelet Volume in the Assessment of Thrombotic Risks in Subjects with Diabetes Mellitus at Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.	PF4 PPBP	3.36e-05	2	202	2	37115730
Pubmed	Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma.	SBNO2 SBNO1	3.36e-05	2	202	2	36695974
Pubmed	The association of genetic variants in toll-like receptor 2 subfamily with allergy and asthma after hospitalization for bronchiolitis in infancy.	TLR6 TLR1	3.36e-05	2	202	2	24445834
Pubmed	Increased Plasma Levels of Platelet Factor 4 and β-thromboglobulin in Women with Recurrent Pregnancy Loss.	PF4 PPBP	3.36e-05	2	202	2	32341585
Pubmed	Chromosomal mapping of two members of the human dynein gene family to chromosome regions 7p15 and 11q13 near the deafness loci DFNA 5 and DFNA 11.	DYNC2H1 DNAH11	3.36e-05	2	202	2	9325061
Pubmed	Association of TGIFLX/Y mRNA expression with prostate cancer.	TGIF2LY TGIF2LX	3.36e-05	2	202	2	18663611
Pubmed	The human-specific Yp11.2/Xq21.3 homology block encodes a potentially functional testis-specific TGIF-like retroposon.	TGIF2LY TGIF2LX	3.36e-05	2	202	2	12226713
Pubmed	Toll-like Receptor 1 743 A>G, 1805 T>G & Toll-like Receptor 6 745 C>T gene polymorphism and tuberculosis: a case control study of north Indian population from Agra (India).	TLR6 TLR1	3.36e-05	2	202	2	24984237
Pubmed	Identification and mutational analysis of candidate genes for juvenile myoclonic epilepsy on 6p11-p12: LRRC1, GCLC, KIAA0057 and CLIC5.	CLIC5 LRRC1	3.36e-05	2	202	2	12200217
Pubmed	Association of TGIFLX/Y mRNA expression with azoospermia in infertile men.	TGIF2LY TGIF2LX	3.36e-05	2	202	2	18384077
Pubmed	SNPs in the exons of Toll-like receptors are associated with susceptibility to type 1 diabetes in Chinese population.	TLR6 TLR1	3.36e-05	2	202	2	25261617
Pubmed	Polymorphisms of PHF11 and DPP10 are associated with asthma and related traits in a Chinese population.	DPP10 PHF11	3.36e-05	2	202	2	19672052
Pubmed	Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease.	CORO1C LRRK2	3.36e-05	2	202	2	33938021
Pubmed	Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.	PF4 PPBP	3.36e-05	2	202	2	18797178
Pubmed	Inflammatory microenvironment and tumor necrosis factor alpha as modulators of periostin and CCN2 expression in human non-healing skin wounds and dermal fibroblasts.	POSTN CCN2	3.36e-05	2	202	2	25779637
Interaction	POLR1G interactions	CMTR1 NOL10 UTP20 NIPBL GNL3 MYBBP1A GNL3L DNAJC8 NSD2 DHX37 POLR2A ZFC3H1 LARP7 ZNF106 BRD2 SBNO1 SLC4A1AP PHF3 ZNF281 TOP2A RSBN1L	1.98e-08	489	200	21	int:POLR1G
Interaction	ZNF330 interactions	NOL10 TRIM24 UTP20 NIPBL GNL3 MYBBP1A GNL3L DNAJC8 NSD2 DHX37 ZFC3H1 LARP7 ZNF106 BRD2 SLC4A1AP PHF3 ZNF281 TOP2A RSBN1L	1.10e-07	446	200	19	int:ZNF330
Interaction	MAGEA9 interactions	SAMD9 MYO9B TRIM24 SPDL1 IQSEC1 SENP5 CCDC14 GNL3L REXO5 ZFC3H1 TXNDC9 TOP2A	1.19e-06	208	200	12	int:MAGEA9
Interaction	PTPRR interactions	CORO1C WASHC5 NTM HSPA4L ARGLU1 ATP5MF CBS EPHA2 PRORP	1.53e-06	110	200	9	int:PTPRR
Interaction	FBXO22 interactions	CYLD CORO1C AK9 MDM2 DIAPH2 GNL3L HSPA4L DHX37 U2SURP POLR2A APOA2 ZNF106 NDUFAF4 RNFT2 SLC4A1AP LMO7 ERCC6L2 RP1 RSBN1L	1.98e-06	540	200	19	int:FBXO22
Interaction	H1-2 interactions	CYLD EPRS1 CMTR1 MYO9B NOL10 FAM186B PYHIN1 REV1 RAD51 ANK2 NSD2 POLR2A ZFC3H1 IFI16 LARP7 ARFGAP2 BRD2 SLC4A1AP PHF3 SBDS EPHA3	3.17e-06	666	200	21	int:H1-2
Interaction	H3C1 interactions	EPRS1 LRRK2 TRIM24 SPDL1 NIPBL GNL3 MYBBP1A KIF23 ANK2 DYNC2H1 DNAJC8 NSD2 DHX37 U2SURP POLR2A LARP7 PIEZO2 BRD2 PHF3 WDR87 TPX2 DNM3 ZNF281 TOP2A RSBN1L	3.43e-06	901	200	25	int:H3C1
Interaction	DHX9 interactions	CYLD EPRS1 CMTR1 MDM2 TRIM24 SPDL1 NIPBL KIF23 HSPA4L DNAJC8 ARGLU1 U2SURP POLR2A L1TD1 IFI16 LARP7 NDUFAF4 SBDS TOP2A INO80B	1.03e-05	662	200	20	int:DHX9
Interaction	TERF2IP interactions	CMTR1 CDK12 TRIM24 CCDC106 NIPBL RAD51 KIF23 DNAJC8 NSD2 U2SURP LARP7 SBNO1 SLC4A1AP PHF3 SBDS TPX2 ZNF281 TOP2A	1.06e-05	552	200	18	int:TERF2IP
Interaction	ANKRD50 interactions	CDK12 PPIG DONSON ARGLU1 ZFC3H1 PHF3 EPHA2 VPS29	1.23e-05	108	200	8	int:ANKRD50
Interaction	RPL31 interactions	CYLD NOL10 MDM2 SPDL1 NGRN UTP20 GNL3 RAD51 MYBBP1A KIF23 GNL3L NSD2 DHX37 U2SURP LARP7 ZNF106 BRD2 TOP2A RSBN1L INO80B	1.52e-05	680	200	20	int:RPL31
Interaction	NUP43 interactions	CDK12 NOL10 CCDC168 FSIP2 UTP20 CHD6 NIPBL GNL3 RAD51 GNL3L ARID4A ARGLU1 NSD2 ZFC3H1 IFI16 LARP7 ZNF281 TOP2A AHNAK2	1.59e-05	625	200	19	int:NUP43
Interaction	NPM1 interactions	CYLD EPRS1 CMTR1 ATR MYO9B NOL10 MDM2 TRIM24 SPDL1 NGRN LARP4B PLCG2 GNL3 SENP5 MYBBP1A KIF23 NSD2 DHX37 GEMIN5 LARP7 SBDS WDR87 RP1 TOP2A RSBN1L VPS29 INO80B AHNAK2	2.24e-05	1201	200	28	int:NPM1
Interaction	DDX23 interactions	CMTR1 CDK12 NOL10 PPIG UTP20 GNL3 MYBBP1A KIF23 ARGLU1 U2SURP IFI16 LARP7 BRD2 PHF3 TOP2A RSBN1L	2.55e-05	480	200	16	int:DDX23
Interaction	NIFK interactions	CDK19 NOL10 UTP20 GNL3 MYBBP1A KIF23 GNL3L DNAJC8 ARGLU1 DHX37 IFI16 LARP7 ZNF106 BRD2 PHF3	2.80e-05	431	200	15	int:NIFK
Interaction	IFI16 interactions	SAMD9 NOL10 MDM2 ADD1 LARP4B UTP20 GNL3 MYBBP1A KIF23 HSPA4L NSD2 DHX37 U2SURP POLR2A IFI16 LARP7 MRM3 SLC4A1AP TOP2A RSBN1L	3.05e-05	714	200	20	int:IFI16
Interaction	H1-4 interactions	CYLD EPRS1 NOL10 PYHIN1 GAPDHS MYBBP1A KIF23 NSD2 DHX37 U2SURP ZFC3H1 IFI16 LARP7 ARFGAP2 BRD2 PHF3 SBDS WDR87 RSBN1L	3.09e-05	656	200	19	int:H1-4
Interaction	SRSF6 interactions	CYLD CMTR1 CDK12 NOL10 NGRN PPIG GNL3 MYBBP1A KIF23 DNAJC8 NSD2 U2SURP ZFC3H1 IFI16 LARP7 RSBN1L	4.47e-05	503	200	16	int:SRSF6
Interaction	AIRE interactions	ATR CHD6 ALOX12B MYBBP1A POLR2A GEMIN5 TOP2A	5.16e-05	97	200	7	int:AIRE
Interaction	H2BC8 interactions	CMTR1 TRIM24 CHD6 NIPBL KIF23 GNL3L ARID4A DNAJC8 NSD2 DHX37 BRD2 SBNO1 SLC4A1AP PHF3 TPX2 ZNF281 TOP2A	6.52e-05	576	200	17	int:H2BC8
Interaction	MDC1 interactions	MDM2 PYHIN1 PYCR1 RAD51 NSD2 U2SURP POLR2A NSMCE3 IFI16 ZNF106 BRD2 SLC4A1AP PHF3 TPX2	7.08e-05	414	200	14	int:MDC1
Interaction	RPL4 interactions	CYLD CDK12 NOL10 MDM2 SPDL1 PYHIN1 GNL3 MYBBP1A KIF23 DNAJC8 NSD2 U2SURP GEMIN5 ZFC3H1 IFI16 LARP7 NLRP14 SBDS TOP2A INO80B	7.78e-05	764	200	20	int:RPL4
Interaction	CDK8 interactions	CDK12 CDK19 MED12L NIPBL POLR2A GEMIN5 MLH3 SBNO1 SLC4A1AP ZNF281	7.82e-05	222	200	10	int:CDK8
Interaction	CBX3 interactions	CDK12 LRRK2 TRIM24 DIAPH2 NIPBL KIF23 DNAJC8 NSD2 POLR2A IFI16 BRD2 SBNO1 SLC4A1AP PHF3 TPX2 ZNF281 TOP2A RSBN1L	8.26e-05	646	200	18	int:CBX3
Interaction	BAZ2A interactions	PYHIN1 DNAJC8 NSD2 IFI16 LARP7 BRD2	8.68e-05	73	200	6	int:BAZ2A
Interaction	DDX46 interactions	MAPKAPK2 SPDL1 DNAH10 DNAJC8 NSD2 U2SURP GEMIN5 LARP7 TPX2 INO80B	9.40e-05	227	200	10	int:DDX46
Interaction	CIT interactions	CYLD MYO9B MAPKAPK2 CORO1C LRRK2 NOL10 CMYA5 PYHIN1 LARP4B PYCR1 UTP20 GAPDHS NIPBL GNL3 RAD51 MYBBP1A KIF23 KALRN DYNC2H1 ARGLU1 POLR2A APOB IFI16 ESYT3 LMO7 TPX2 ZNF281 TOP2A RSBN1L AHNAK2	1.01e-04	1450	200	30	int:CIT
Interaction	PARP1 interactions	CYLD CMTR1 CORO1C NOL10 MDM2 PYHIN1 LARP4B SACS UTP20 CHD6 NIPBL GNL3 KIF23 DNAJC8 NSD2 DHX37 U2SURP POLR2A IFI16 LARP7 ZNF106 BRD2 LMO7 PHF3 TPX2 ZNF281 TOP2A RSBN1L	1.10e-04	1316	200	28	int:PARP1
Interaction	FOXP3 interactions	ATR CORO1C NOL10 MDM2 ADD1 PPIG RAD51 NSD2 DHX37 POLR2A KRIT1 ARFGAP2 PHF3 FYB1	1.11e-04	432	200	14	int:FOXP3
Interaction	RPS16 interactions	CYLD EPRS1 CMTR1 TRIM24 SPDL1 LRRC47 LARP4B GNL3 MYBBP1A KIF23 NSD2 DHX37 U2SURP GEMIN5 LARP7 MRM3 TOP2A RSBN1L INO80B	1.15e-04	724	200	19	int:RPS16
Interaction	PHLPP1 interactions	EPRS1 CORO1C CMYA5 SPDL1 MYBBP1A KIF23 POLR2A GEMIN5 LMO7 EPHA2 TPX2 AHNAK2	1.30e-04	333	200	12	int:PHLPP1
Interaction	H3C3 interactions	TRIM24 FSIP2 CHD6 NIPBL KIF23 GNL3L ARID4A NSD2 DHX37 BRD2 SBNO1 PHF3 TPX2 ZNF281 TOP2A	1.33e-04	495	200	15	int:H3C3
Interaction	BIRC3 interactions	EPRS1 ATR TRIO CORO1C RTN3 NOL10 CMYA5 SPDL1 LRRC47 PYCR1 UTP20 GNL3 MYBBP1A KIF23 GNL3L DNAH10 HSPA4L DYNC2H1 DNAJC8 DHX37 U2SURP POLR2A GEMIN5 APOB CBS MRM3 GFM1 TOP2A	1.39e-04	1334	200	28	int:BIRC3
Interaction	MIRLET7I interactions	EPRS1 UTP20 TUT4 DHX37 U2SURP LARP7 ZNF106	1.43e-04	114	200	7	int:MIRLET7I
Interaction	MIR143 interactions	EPRS1 UTP20 TUT4 DHX37 U2SURP LARP7	1.45e-04	80	200	6	int:MIR143
Interaction	CBLB interactions	CYLD LRRK2 UBASH3A PLCG2 GLRX3 EPHA2 FYB1	1.51e-04	115	200	7	int:CBLB
Interaction	SMC5 interactions	EPRS1 CDK12 NOL10 TRIM24 NIPBL GNL3 MYBBP1A KIF23 ARID4A DNAJC8 ARGLU1 NSD2 U2SURP POLR2A NSMCE3 BRD2 SLC4A1AP PHF3 TPX2 ZNF281 TOP2A RSBN1L INO80B	1.56e-04	1000	200	23	int:SMC5
Interaction	CSNK2B interactions	MAPKAPK2 MDM2 ADD1 PYHIN1 CCDC106 RAD51 ARGLU1 U2SURP POLR2A IFI16 LARP7 ZNF106 SNCAIP BRD2 PHF11 TOP2A INO80B	1.74e-04	625	200	17	int:CSNK2B
Interaction	GNL3L interactions	CDK12 MDM2 PYHIN1 GNL3 GNL3L DONSON CEP192 LARP7	1.77e-04	157	200	8	int:GNL3L
Interaction	PFN1 interactions	CYLD TRIO MYO9B VPS13C RTN3 TRIM24 PPIG DIAPH2 RAD51 ANK2 CEP192 LARP7 ARFGAP2 KIF13A AHNAK2	1.80e-04	509	200	15	int:PFN1
Interaction	ODF2 interactions	CYLD EPRS1 CCDC14 DNAJC8 CEP192 LMO7 INO80B EXOC4	1.85e-04	158	200	8	int:ODF2
Interaction	MED30 interactions	CDK19 MED12L POLR2A APOA2 CARTPT BRD2	1.89e-04	84	200	6	int:MED30
Interaction	MED17 interactions	CMTR1 CDK19 MED12L DONSON POLR2A APOA2 LARP7 SBNO1 SBDS	1.94e-04	202	200	9	int:MED17
Interaction	SLX4 interactions	CMTR1 TRIM24 SPDL1 IQSEC1 NIPBL REV1 KIF23 POLR2A ZFC3H1 ZNF106 MLH3 BRD2 SBNO1 LRRC1 TPX2 ZNF281	1.98e-04	572	200	16	int:SLX4
Interaction	RAD18 interactions	EPRS1 CDK12 CORO1C TRIM24 PPIG RAD51 DNAJC8 ARGLU1 LLGL2 BRD2 SLC4A1AP LMO7 EPHA2 TOP2A	1.99e-04	457	200	14	int:RAD18
Interaction	ASF1A interactions	CMTR1 TRIM24 CHD6 KIF23 POLR2A ARFGAP2 BRD2 PHF3 TPX2 ZNF281	2.00e-04	249	200	10	int:ASF1A
Interaction	MIR93 interactions	EPRS1 UTP20 DHX37 U2SURP LARP7 ZNF106	2.02e-04	85	200	6	int:MIR93
Interaction	TPX2 interactions	CDK12 PLEKHM1 PPIG DNAJC8 ARGLU1 NSD2 PHF3 EPHA2 TPX2	2.08e-04	204	200	9	int:TPX2
Interaction	DHX30 interactions	CYLD CMTR1 LRRK2 TRIM24 NGRN PYCR1 MYBBP1A KIF23 ZFC3H1 IFI16 LARP7 MRM3 GFM1 TOP2A INO80B	2.12e-04	517	200	15	int:DHX30
Interaction	SRSF4 interactions	CMTR1 CDK12 PYHIN1 NGRN PPIG ARGLU1 NSD2 U2SURP IFI16 LARP7 RSBN1L	2.13e-04	300	200	11	int:SRSF4
Interaction	RIT1 interactions	EPRS1 CMTR1 ATR CDK12 LRRK2 NOL10 SPDL1 UTP20 NIPBL GNL3 RAD51 KIF23 ISCA1 DNAJC8 DHX37 U2SURP ATP5MF NSMCE3 PLEKHG6 SBNO1 SBDS TPX2 PRORP GFM1 TOP2A SLC35B1	2.20e-04	1230	200	26	int:RIT1
Interaction	H1-5 interactions	CMTR1 MYO9B CCDC168 TBC1D32 KIF23 NSD2 U2SURP ZFC3H1 LARP7 SLC4A1AP LMO7 PHF3 WDR87 PHF11	2.27e-04	463	200	14	int:H1-5
Interaction	MIR138-2 interactions	EPRS1 UTP20 DHX37 U2SURP LARP7 ZNF106	2.44e-04	88	200	6	int:MIR138-2
Interaction	RPS24 interactions	CYLD CMTR1 NOL10 CCDC168 PYHIN1 LARP4B UTP20 GNL3 MYBBP1A KIF23 GNL3L DHX37 LARP7 ZNF106 TOP2A	2.71e-04	529	200	15	int:RPS24
Interaction	SUMO2 interactions	EPRS1 LRRK2 TRIM24 LARP4B NIPBL SENP5 RAD51 KIF23 KALRN POLR2A GEMIN5 LMO7 PHF3 TPX2 TOP2A AHNAK2	2.85e-04	591	200	16	int:SUMO2
Interaction	SRSF5 interactions	CYLD CMTR1 CDK12 NOL10 PPIG GAPDHS MYBBP1A KIF23 NSD2 DHX37 U2SURP IFI16 LARP7 RSBN1L	2.89e-04	474	200	14	int:SRSF5
Interaction	RSL1D1 interactions	MDM2 PYHIN1 NGRN MYBBP1A KIF23 ARGLU1 NSD2 U2SURP PTPN21 IFI16 LARP7 PHF3 CFAP44 INO80B	3.21e-04	479	200	14	int:RSL1D1
Interaction	HECTD1 interactions	EPRS1 MYO9B CDK12 NOL10 LARP4B UTP20 GNL3 RAD51 MYBBP1A KIF23 HSPA4L NSD2 DHX37 U2SURP ZFC3H1 LARP7 MRM3 PHF3 TPX2 DNM3 TOP2A EXOC4	3.24e-04	984	200	22	int:HECTD1
Interaction	CDC5L interactions	CYLD CMTR1 ATR TRIO MED12L NIPBL MYBBP1A KALRN ARGLU1 SMARCAL1 U2SURP POLR2A IFI16 LARP7 BRD2 LMO7 LRRC1 TPX2 TOP2A EXOC4	3.45e-04	855	200	20	int:CDC5L
Interaction	UBE2O interactions	CORO1C AK9 MDM2 PPIG PYCR1 CCDC106 GNL3 MYBBP1A KIF23 GNL3L DYNC2H1 DNAJC8 ARGLU1 U2SURP ATP5MF APOB LLGL2 BRD2 SBDS	3.46e-04	790	200	19	int:UBE2O
Interaction	ATRX interactions	CDK12 LRRK2 MDM2 PYHIN1 RAD51 ANK2 DNAJC8 NSD2 CBS ZNF281	3.49e-04	267	200	10	int:ATRX
Interaction	MIRLET7F1 interactions	EPRS1 UTP20 TUT4 DHX37 U2SURP LARP7	3.50e-04	94	200	6	int:MIRLET7F1
GeneFamily	Dyneins, axonemal	DNAH10 DNAH7 DNAH11	2.24e-04	17	129	3	536
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCL2 PLCB2 PLCG2	3.16e-04	19	129	3	832
GeneFamily	Sterile alpha motif domain containing	SAMD9 ARAP2 SASH1 EPHA2 EPHA3	4.17e-04	88	129	5	760
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	PYHIN1 IFI16	4.98e-04	5	129	2	995
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	PYHIN1 IFI16 NLRP14	7.28e-04	25	129	3	994
GeneFamily	La ribonucleoprotein domain containing\|RNA binding motif containing	LARP4B LARP7	1.04e-03	7	129	2	625
GeneFamily	CD molecules\|Toll like receptors	TLR6 TLR1	2.19e-03	10	129	2	948
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	EPRS1 ATR VPS13C TRIM24 SPDL1 PPIG SACS WASHC5 CPLANE1 NIPBL KIF23 TUT4 HSPA4L DNAJC8 L1TD1 CEP192 IFI16 LARP7 KRIT1 PIEZO2 ABCA5 SLC4A1AP PHF3 FYB1	2.50e-10	656	200	24	M18979
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	SECISBP2L HGF ABAT CMTR1 SEPTIN6 PPIG PLCL2 DIAPH2 GAPDHS ARAP2 PMP2 KALRN ARID4A ATP5MF IFI16 LARP7 KRIT1 PHF3 TXNDC9 SLC35B1	5.25e-07	705	200	20	M1410
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SECISBP2L ATR TRIO MYO9B CDK19 TRIM24 LARP4B SACS UTP20 NIPBL ARAP2 KIF23 TUT4 SASH1 ARID4A U2SURP KRIT1 MICAL2 PHF3 TMEM131 CCN2 TOP2A	7.25e-07	856	200	22	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CYLD SAMD9 ATR MYO9B VPS13C UBASH3A SEPTIN6 ADD1 PYHIN1 PPIG CLIC5 SACS PLCB2 NIPBL ARAP2 TUT4 ARID4A LONP2 U2SURP PHTF2 ZFC3H1 IFI16 SBNO2 CCDC88C SBNO1 PHF3 PHF11 FYB1	9.98e-06	1492	200	28	M40023
Coexpression	GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS	CCDC60 BPIFB1 AK9 C6orf118 PLCB2 PLCG2 CPLANE1 DNAH10 DYNC2H1 DNAH7 CCDC88C CCN2 CFAP44 DNAH11	1.28e-05	459	200	14	M39136
Coexpression	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	SECISBP2L MYO9B MAPKAPK2 PLEKHM1 SEPTIN6 DIAPH2 AIF1 UTP20 VWF LONP2 PPBP KRIT1 BRD2 ABCA5	1.71e-05	471	200	14	M19016
Coexpression	ABRAMSON_INTERACT_WITH_AIRE	CHD6 MYBBP1A POLR2A GEMIN5 TOP2A	2.10e-05	44	200	5	M2536
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN	EPRS1 CDK19 ABCD2 RAD51 CCDC14 DONSON NSD2 TOP2A VPS29	2.27e-05	198	200	9	M8274
Coexpression	GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	CYLD PF4 ADD1 SACS REXO5 NSD2 MICAL2 MMUT SLC35B1	2.36e-05	199	200	9	M8418
Coexpression	ROPERO_HDAC2_TARGETS	CORO1C TLR6 MDM2 SEPTIN6 APOA2 CCDC88C EPHA2	2.50e-05	112	200	7	M8759
Coexpression	PATIL_LIVER_CANCER	TRIO RTN3 TRIM24 WASHC5 CCDC14 KIF23 VWF DONSON RGS5 U2SURP CEP192 PIEZO2 TPX2 AACS POFUT1 TOP2A	5.10e-05	660	200	16	M1195
Coexpression	BENPORATH_NANOG_TARGETS	CYLD TRIM24 SEPTIN6 MYO3A SASH1 DNAJC8 PHTF2 APOA2 APOB NSMCE3 IFI16 LARP7 SLC4A1AP COMMD7 TPX2 CCN2 PRORP ZNF281 TOP2A EXOC4	7.38e-05	988	200	20	M6616
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MYO9B VPS13C MED12L ARAP2 TUT4 NSD2 ZNF106 SBNO1	7.61e-05	180	200	8	M8239
Coexpression	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	HGF PF4 RAD51 PPBP PIEZO2 MICAL2 TPX2 TOP2A	9.22e-05	185	200	8	M3155
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_UP	EPRS1 ADD1 SPDL1 RAD51 KIF23 GFM1 TOP2A EPHA3	9.22e-05	185	200	8	M374
Coexpression	ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR	PF4 VWF KALRN PPBP DNM3 FYB1	1.08e-04	98	200	6	M39210
Coexpression	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	PF4 PPBP PIEZO2	1.18e-04	13	200	3	M19476
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	KIF23 TUT4 LARP7 MLH3 MICAL2 PHF3 TOP2A	1.29e-04	145	200	7	M1810
Coexpression	PILON_KLF1_TARGETS_UP	CYLD TRIO MDM2 LARP4B NRK GNL3L VWF APOA2 APOB PPBP ARFGAP2 SBNO1 TOP2A	1.40e-04	503	200	13	M2226
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	EPRS1 SAMD9 ATR TRIO CORO1C NIPBL SENP5 DYNC2H1 GLRX3 U2SURP IFI16 MICAL2 TPX2 TXNDC9 TOP2A AHNAK2	1.42e-04	721	200	16	M10237
Coexpression	BENPORATH_CYCLING_GENES	MDM2 SPDL1 CPLANE1 NIPBL RAD51 CCDC14 KIF23 DONSON ARGLU1 LARP7 SLC4A1AP TPX2 TXNDC9 ZNF281 TOP2A	1.46e-04	648	200	15	M8156
Coexpression	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP	HGF PLCL2 IQSEC1 CILP LONP2 ARGLU1 PHF11 FYB1	1.47e-04	198	200	8	M5302
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	SECISBP2L CDK12 PLCG2 ARAP2 LARP7 KRIT1 TXNDC9 MMUT	1.47e-04	198	200	8	M4424
Coexpression	GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	SPDL1 LRRC47 PPIG TUT4 LONP2 DNAJC8 SLC4A1AP RSBN1L	1.53e-04	199	200	8	M3328
Coexpression	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN	MDM2 AIF1 GNL3 DNAJC8 ABCA5 SBDS FYB1 MMUT	1.58e-04	200	200	8	M5801
Coexpression	GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP	CORO1C NIPBL GLRX3 KRIT1 NDUFAF4 BRD2 LRRC1 VPS29	1.58e-04	200	200	8	M4841
Coexpression	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP	RTN3 LRRC47 WASHC5 UTP20 PLCG2 KALRN TMTC4 MMUT	1.58e-04	200	200	8	M5627
Coexpression	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	EPRS1 SACS RAD51 NSD2 GEMIN5 NDUFAF4 TPX2 AACS	1.58e-04	200	200	8	M6989
Coexpression	WHITFIELD_CELL_CYCLE_S	CPLANE1 RAD51 CCDC14 DONSON PHTF2 ABCA5 TOP2A	1.59e-04	150	200	7	M2075
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	SECISBP2L EPRS1 CDK12 TLR6 ADD1 PPIG LARP4B SACS PLCL2 IQSEC1 NIPBL ARAP2 ISCA1 GNL3L LONP2 DNAJC8 GLRX3 SMARCAL1 U2SURP ZNF106 AACS TMEM131	1.60e-04	1215	200	22	M41122
Coexpression	GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS	MYO3A RAD51 KIF23 REXO5 TPX2 TOP2A	1.75e-04	107	200	6	M39165
Coexpression	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	RAD51 NSD2 LLGL2 RNFT2 ABCA5 CCN2	1.75e-04	107	200	6	M8268
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	CORO1C TLR6 SPDL1 MYO3A SACS RAD51 KIF23 REXO5 DONSON NSD2 PHTF2 LMO7 TPX2 TOP2A	1.82e-04	588	200	14	M38992
Coexpression	CHANDRAN_METASTASIS_UP	TRIO ADD1 NTM GNL3L DONSON POLR2A TPX2 ZNF281	2.13e-04	209	200	8	M16036
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ATR TRIM24 SPDL1 PPIG CLIC5 DIAPH2 UTP20 CPLANE1 NIPBL GNL3 TUT4 GNL3L DONSON TTC41P ANK2 ARID4A HSPA4L DNAJC8 ARGLU1 NSD2 CEP192 LARP7 CCDC88C NDUFAF4 SBNO1 SLC4A1AP PHF3 TET1 PHF11 TPX2 ZNF281 TOP2A EPHA3	1.88e-06	1459	198	33	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ATR TRIM24 SPDL1 PPIG CLIC5 DIAPH2 UTP20 CPLANE1 NIPBL GNL3 TUT4 GNL3L DONSON TTC41P ANK2 ARID4A DNAJC8 ARGLU1 NSD2 CEP192 LARP7 CCDC88C NDUFAF4 SBNO1 SLC4A1AP PHF3 TET1 TPX2 ZNF281 TOP2A	2.02e-06	1257	198	30	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	PF4 NRK AIF1 RGS5 POSTN PIEZO2 FYB1	1.16e-05	82	198	7	gudmap_kidney_e13.5_Podocyte_MafB_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	ATR CDK12 TBC1D32 UTP20 CPLANE1 GNL3 REV1 RAD51 MYBBP1A ARID4A HSPA4L L1TD1 PHTF2 GEMIN5 CEP192 TMTC4 SBNO1 TET1 PHF11 PRORP FYB1	2.39e-05	810	198	21	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	HGF LRRK2 NTM ABCD2 NIPBL RAD51 CCDC14 DPP10 ARID4A PHTF2 IFI16 POSTN PIEZO2 TMTC4 ABCA5 TLR1 TET1 COMMD7 TPX2 ERCC6L2 CACNA2D3	2.81e-05	819	198	21	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	EPRS1 CDK12 VPS13C SPDL1 LARP4B NIPBL KIF23 DONSON ARGLU1 DHX37 CEP192 LARP7 ZNF106 NDUFAF4 PHF3 TPX2	4.17e-05	532	198	16	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	VPS13C PF4 CLIC5 NRK MED12L UTP20 CHD6 ARAP2 ANK2 DNAH10 HSPA4L RGS5 FAT3 POSTN CCDC88C CD1D NDUFAF4 SLC4A1AP LRRC1 TPX2 DNM3 FYB1 EPHA3	4.78e-05	983	198	23	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000	ABAT C6orf118 CLIC5 NTM MED12L DPP10 DONSON ANK2 CILP KALRN L1TD1 POSTN PIEZO2 SNCAIP TMTC4 ABCA5 TLR1 COMMD7 FYB1 CACNA2D3 EPHA3	5.23e-05	855	198	21	gudmap_developingKidney_e13.5_podocyte cells_1000
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000	ABAT NTM DPP10 ANK2 CILP POSTN TMTC4 ABCA5 CACNA2D3 EPHA3	1.25e-04	250	198	10	gudmap_developingKidney_e13.5_podocyte cells_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	CDK12 KLHL41 NIPBL KIF23 CEP192 LARP7 CCDC88C PHF3 TET1 LRRC1	1.67e-04	259	198	10	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC60 C6orf118 CPLANE1 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 AHNAK2 DNAH11	1.94e-08	193	201	10	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYLD UBASH3A SEPTIN6 PYHIN1 ABCD2 ARAP2 PHTF2 IFI16 CCDC88C FYB1	2.04e-08	194	201	10	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	VPS13C PPIG NIPBL U2SURP LARP7 ZNF106 SBNO1 LMO7 PHF3 ZNF281	2.60e-08	199	201	10	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHAD CMYA5 DIAPH2 CHD6 PLCG2 ALOX12B CCDC14 FAT3 FYB1	7.59e-08	168	201	9	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 CCDC88C RP1 CFAP44 DNAH11	7.98e-08	169	201	9	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	CCDC60 AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.37e-07	192	201	9	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	C6orf118 DIAPH2 DNAH10 DYNC2H1 DNAH7 CCN2 RP1 CFAP44 DNAH11	2.70e-07	195	201	9	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	CCDC60 C6orf118 DNAH10 DYNC2H1 DNAH7 LMO7 RP1 CFAP44 DNAH11	2.82e-07	196	201	9	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 C6orf118 CPLANE1 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.94e-07	197	201	9	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	C6orf118 DIAPH2 DNAH10 DYNC2H1 DNAH7 CCN2 RP1 CFAP44 DNAH11	2.94e-07	197	201	9	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	C6orf118 DIAPH2 DNAH10 DYNC2H1 DNAH7 CCN2 RP1 CFAP44 DNAH11	2.94e-07	197	201	9	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AK9 C6orf118 DIAPH2 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.07e-07	198	201	9	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 VPS13C PLCG2 NIPBL ARAP2 ARGLU1 ZFC3H1 IFI16 PHF3	3.34e-07	200	201	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CCDC60 AK9 C6orf118 ALOX12B LRRC18 DNAH10 DNAH7 RP1 CFAP44	3.34e-07	200	201	9	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCDC60 NTM PLCB2 PLCG2 ALOX12B CCDC14 HSPA4L FYB1	5.69e-07	156	201	8	58b9520fce6e259b36c3d59e82b712f5e7729e3e
ToppCell	Dendritic_Cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	TLR6 ADAM28 AIF1 IFI16 CD1D TLR1 FYB1 CACNA2D3	9.10e-07	166	201	8	fbeb74b98b58085de323f744b18d4a8f7b22d5d4
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRK2 BPIFB1 SEPTIN6 AIF1 PLCB2 ESYT3 LRRC1 PHF11	1.19e-06	172	201	8	a5344760b10ecdc0101f78b93b8fc0f8107068c5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLIC5 ARAP2 PTPN21 LLGL2 LMO7 LRRC1 RP1 CACNA2D3	1.60e-06	179	201	8	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CLIC5 NTM ARAP2 ESYT3 LLGL2 LMO7 MICAL2 LRRC1	1.89e-06	183	201	8	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CLIC5 NTM ARAP2 PTPN21 LLGL2 LMO7 MICAL2 LRRC1	1.97e-06	184	201	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	CLIC5 NTM ARAP2 PTPN21 LLGL2 LMO7 LRRC1 RP1	1.97e-06	184	201	8	561592edc3083fad41b91811151b442207c65dd9
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CLIC5 NTM ARAP2 PTPN21 LLGL2 LMO7 MICAL2 LRRC1	1.97e-06	184	201	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLIC5 ARAP2 PTPN21 LLGL2 LMO7 LRRC1 RP1 CACNA2D3	2.05e-06	185	201	8	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	CLIC5 NTM CPLANE1 ARAP2 PTPN21 LLGL2 LMO7 LRRC1	2.05e-06	185	201	8	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	CLIC5 NTM ARAP2 PTPN21 LLGL2 LMO7 LRRC1 CACNA2D3	2.22e-06	187	201	8	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	CLIC5 NTM ARAP2 PTPN21 LLGL2 LMO7 LRRC1 CACNA2D3	2.40e-06	189	201	8	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.40e-06	189	201	8	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEXMIF BPIFB1 NRK VWF GARIN2 SNCAIP MICAL2 LRRC1	2.60e-06	191	201	8	4bfdf44d4402a42530d30c89d94946acdda4321b
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLCB2 CHD6 PLCG2 ALOX12B CCDC14 POLR2A L1TD1 FYB1	2.60e-06	191	201	8	54f07e4de61735051498846afb44b1798bed8144
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	CCDC60 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.70e-06	192	201	8	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	multiciliated\|World / shred by cell class for turbinate	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.70e-06	192	201	8	0f89ea0deb651ca11531c51ee94e0233608d22ea
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HGF EPRS1 CMYA5 NTM NRK PIEZO2 SNCAIP EPHA3	2.81e-06	193	201	8	7cd9671e0ac64f7f3607f564485c63abbb7e7a63
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.81e-06	193	201	8	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.81e-06	193	201	8	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 PLCG2 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.92e-06	194	201	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	CCDC60 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.92e-06	194	201	8	958e648138676d46698090b4046cb484083ae449
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.03e-06	195	201	8	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BPIFB1 AK9 C6orf118 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.03e-06	195	201	8	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.03e-06	195	201	8	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.03e-06	195	201	8	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C6orf118 CPLANE1 DNAH10 DNAH7 RNFT2 RP1 CFAP44 DNAH11	3.03e-06	195	201	8	79dc031258579ea328181dda33710dd897f1064a
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	C6orf118 DNAH10 DYNC2H1 DNAH7 CCN2 RP1 CFAP44 DNAH11	3.03e-06	195	201	8	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CCDC60 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.15e-06	196	201	8	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.27e-06	197	201	8	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C6orf118 DIAPH2 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.27e-06	197	201	8	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CLIC5 NTM ARAP2 PTPN21 LLGL2 LMO7 LRRC1 RP1	3.27e-06	197	201	8	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	VPS13C PPIG NIPBL U2SURP LARP7 SBNO1 LMO7 PHF3	3.52e-06	199	201	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CCDC60 AK9 C6orf118 ALOX12B DNAH10 DNAH7 RP1 CFAP44	3.52e-06	199	201	8	15f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	NTM PYCR1 DONSON CILP POSTN SUGCT MICAL2 CACNA2D3	3.52e-06	199	201	8	f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	VPS13C RTN3 NTM NIPBL FAT3 IFI16 PHF3 AHNAK2	3.52e-06	199	201	8	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	3.66e-06	200	201	8	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CCDC60 AK9 C6orf118 ALOX12B DNAH10 DNAH7 RP1 CFAP44	3.66e-06	200	201	8	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	E16.5-samps-Myeloid-Macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PF4 AIF1 CCDC106 SASH1 TLR1 RP1 FYB1	5.02e-06	148	201	7	cd5f697d8c2f272be1f3f52a05446749278431c5
ToppCell	E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PF4 AIF1 CCDC106 SASH1 TLR1 RP1 FYB1	5.02e-06	148	201	7	56e146980a71b5ca655118ae13310c5949220d4a
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	CCDC60 BPIFB1 DNAH10 DNAH7 LMO7 RP1 DNAH11	5.73e-06	151	201	7	8216462e723fec2797387929dde095370947e10a
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NEXMIF MED12L KY PLEKHG6 LMO7 RP1 INO80B	1.02e-05	165	201	7	f6887c64af0f26e33316bc5587487e24d76ece2a
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C LRRK2 UTP20 CCDC106 CPLANE1 TMTC4 DNAH11	1.15e-05	168	201	7	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	Control-T_cells-Tregs\|Control / group, cell type (main and fine annotations)	UBASH3A SEPTIN6 PYHIN1 PHTF2 IFI16 CCDC88C FYB1	1.20e-05	169	201	7	e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 CPLANE1 DNAH10 DYNC2H1 DNAH7 RP1 DNAH11	1.20e-05	169	201	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	facs-Aorta-Heart-3m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEPTIN6 PYHIN1 AIF1 PLCB2 PLCG2 ISCA1 TOP2A	1.39e-05	173	201	7	513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PF4 WASHC5 AIF1 CCDC106 SLC9A1 TPX2 TOP2A	1.39e-05	173	201	7	12c6875f881cb0fbff09d753b53c1cce7a95527f
ToppCell	AT1_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	CLIC5 NTM NRK PTPN21 LLGL2 PLEKHG6 LMO7	1.39e-05	173	201	7	b29816427428c7053017477f59b828bf1357f3b2
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NTM KIF23 CILP POSTN MICAL2 TPX2 TOP2A	1.45e-05	174	201	7	1779e67382cb2644534ffb5b9b8f28d32935f4ea
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	CLIC5 NTM ARAP2 PTPN21 LMO7 LRRC1 RP1	1.45e-05	174	201	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	SAMD9 ARAP2 REV1 HSPA4L IFI16 EPHA2 LRRC1	1.50e-05	175	201	7	0cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell	facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM47E LRRC18 DNAH10 KY RP1 CFAP44 DNAH11	1.56e-05	176	201	7	ed788a5969edfd1199828ca5b0dd34e7f29c4d30
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BPIFB1 AK9 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	1.56e-05	176	201	7	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDK12 VPS13C CLIC5 DIAPH2 ARAP2 CCDC88C LMO7	1.67e-05	178	201	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CMYA5 ADAM28 PLCG2 ARGLU1 NSD2 LMO7 EPHA2	1.74e-05	179	201	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 C6orf118 DNAH10 DYNC2H1 DNAH7 KY DNAH11	1.74e-05	179	201	7	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NTM NRK CCDC106 CCDC14 POSTN DNM3 AHNAK2	1.74e-05	179	201	7	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	CLIC5 NTM PTPN21 LLGL2 LMO7 LRRC1 CCN2	1.80e-05	180	201	7	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 DYNC2H1 DNAH7 RNFT2 RP1 CFAP44 DNAH11	1.80e-05	180	201	7	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 NTM NRK ANK2 SASH1 DNM3 CACNA2D3	1.86e-05	181	201	7	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 NTM NRK ANK2 SASH1 DNM3 CACNA2D3	1.93e-05	182	201	7	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CCDC60 C6orf118 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	1.93e-05	182	201	7	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UBASH3A SEPTIN6 PYHIN1 PLCG2 GAPDHS ARAP2 FYB1	2.00e-05	183	201	7	59e8d07556390828f7557ba3fd2f7d49851498b7
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	CLIC5 NTM PTPN21 LLGL2 LMO7 MICAL2 LRRC1	2.00e-05	183	201	7	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRK DNAH10 KALRN FAT3 APOB PIEZO2 DNAH11	2.07e-05	184	201	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRK DNAH10 KALRN FAT3 APOB PIEZO2 DNAH11	2.07e-05	184	201	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRK DNAH10 KALRN FAT3 APOB PIEZO2 DNAH11	2.07e-05	184	201	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Ciliated_cells-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CCDC60 BPIFB1 C6orf118 DNAH10 DNAH7 RP1 DNAH11	2.07e-05	184	201	7	07c5a9633ccdcd18771e3230d6198a55c400afa6
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.15e-05	185	201	7	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CCDC60 C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 DNAH11	2.15e-05	185	201	7	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 NRK SASH1 DNAH7 RP1 CACNA2D3 DNAH11	2.22e-05	186	201	7	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C6orf118 DNAH10 DYNC2H1 DNAH7 RP1 CFAP44 DNAH11	2.22e-05	186	201	7	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	CLIC5 ARAP2 PTPN21 LLGL2 LMO7 LRRC1 RP1	2.22e-05	186	201	7	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	UBASH3A SEPTIN6 PYHIN1 PLCL2 IFI16 CCDC88C FYB1	2.30e-05	187	201	7	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLIC5 ARAP2 PTPN21 LLGL2 LMO7 LRRC1 CACNA2D3	2.30e-05	187	201	7	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRK2 PYHIN1 IQSEC1 PLCG2 ARGLU1 APOA2 TLR1	2.30e-05	187	201	7	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	human_hepatoblastoma-NK.T_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	UBASH3A PYHIN1 PLCL2 ARAP2 IFI16 CCDC88C FYB1	2.38e-05	188	201	7	71b7599e7e1d63cc0c8518c0501533755951d58f
ToppCell	Fibroblast-E_(Early_Fibroblastic_progenitor)\|World / shred on cell class and cell subclass (v4)	SPDL1 RAD51 KIF23 NSD2 POSTN TPX2 TOP2A	2.38e-05	188	201	7	be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO LRRK2 NTM SASH1 DNM3 CACNA2D3 DNAH11	2.38e-05	188	201	7	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	COVID-19-T_cells-CD8+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	UBASH3A SEPTIN6 PYHIN1 ABCD2 ARAP2 CCDC88C FYB1	2.46e-05	189	201	7	2c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEXMIF LRRK2 NRK LLGL2 LMO7 RP1 CACNA2D3	2.46e-05	189	201	7	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPY19L2P1 ARAP2 DPP10 KALRN FAT3 MICAL2 CACNA2D3	2.46e-05	189	201	7	a75226616340045b581d08429d2e123e041dee55
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	C6orf118 DNAH10 DYNC2H1 DNAH7 CCN2 RP1 DNAH11	2.55e-05	190	201	7	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|World / Lineage and Cell class	PF4 MED12L VWF KALRN PPBP PIEZO2 DNM3	2.55e-05	190	201	7	1d19b2bd55789bf13e1386332f46c605973d6f8e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPY19L2P1 ARAP2 KALRN FAT3 LMO7 MICAL2 CACNA2D3	2.55e-05	190	201	7	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	C6orf118 DNAH10 DYNC2H1 DNAH7 CCN2 RP1 DNAH11	2.55e-05	190	201	7	833481ace2800354712e2ce709d5cdfd0aed3d42
Disease	familial combined hyperlipidemia (is_marker_for)	VWF APOA2 APOB	5.78e-06	6	197	3	DOID:13809 (is_marker_for)
Disease	Squamous cell carcinoma of lung	ATR TRIM24 EPHA2 EPHA3	5.99e-05	32	197	4	C0149782
Disease	chymotrypsin-C measurement	PF4 PPBP	1.32e-04	3	197	2	EFO_0802398
Disease	annexin A6 measurement	PF4 PPBP	1.32e-04	3	197	2	EFO_0020151
Disease	72 kDa inositol polyphosphate 5-phosphatase measurement	PF4 PPBP	2.64e-04	4	197	2	EFO_0802244
Disease	liver fibrosis measurement	TDRD15 NOL10 VWF APOB DNM3	2.83e-04	86	197	5	EFO_0010576
Disease	platelet measurement	MYO9B LRRK2 C6orf118 MED12L PLCG2 GAPDHS VWF KALRN DNM3	2.85e-04	315	197	9	EFO_0005036
Disease	Colorectal Carcinoma	LRRC47 SACS ABCD2 DONSON ANK2 KALRN APOB POSTN MLH3 ABCA5 LMO7 TPX2 EPHA3 EXOC4	2.85e-04	702	197	14	C0009402
Disease	tetratricopeptide repeat protein 17 measurement	PF4 PPBP	4.38e-04	5	197	2	EFO_0803144
Disease	histone-lysine N-methyltransferase SETD2 measurement	PF4 PPBP	4.38e-04	5	197	2	EFO_0802604
Disease	Ovarian Serous Adenocarcinoma	LRRK2 TRIM24 MYO3A	4.70e-04	23	197	3	C1335177
Disease	breast cancer (implicated_via_orthology)	ATR RAD51 CBS	6.05e-04	25	197	3	DOID:1612 (implicated_via_orthology)
Disease	Dwarfism	IQSEC1 DONSON LARP7	6.05e-04	25	197	3	C0013336
Disease	VACTERL association (implicated_via_orthology)	TBC1D32 DYNC2H1	6.54e-04	6	197	2	DOID:14679 (implicated_via_orthology)
Disease	tendinitis (biomarker_via_orthology)	POSTN CCN2	6.54e-04	6	197	2	DOID:971 (biomarker_via_orthology)
Disease	hypertension, white matter hyperintensity measurement	RASL12 CCDC88C ZNF106 SNCAIP	7.94e-04	62	197	4	EFO_0000537, EFO_0005665
Disease	Headache, HOMA-B	ZNF106 SNCAIP	9.11e-04	7	197	2	EFO_0004469, HP_0002315
Disease	biliary tract benign neoplasm (is_marker_for)	HGF MDM2	9.11e-04	7	197	2	DOID:0050625 (is_marker_for)
Disease	Malignant neoplasm of breast	MDM2 UTP20 NIPBL RAD51 VWF ANK2 KALRN DYNC2H1 VPS39 NSD2 SMARCAL1 NLRP14 LLGL2 TMTC4 SBNO1 ZNF281 TOP2A	9.22e-04	1074	197	17	C0006142
Disease	selenium measurement	CMYA5 DYNC2H1 CBS	9.42e-04	29	197	3	EFO_0006331
Disease	Prostatic Neoplasms	SAMD9 ATR CDK12 TLR6 MDM2 ADAM28 PYHIN1 CHD6 ALOX12B MYBBP1A ARID4A TOP2A	9.47e-04	616	197	12	C0033578
Disease	Malignant neoplasm of prostate	SAMD9 ATR CDK12 TLR6 MDM2 ADAM28 PYHIN1 CHD6 ALOX12B MYBBP1A ARID4A TOP2A	9.47e-04	616	197	12	C0376358
Disease	factor VIII measurement, coronary artery disease	TDRD15 VWF DYNC2H1 APOB RP1	9.88e-04	113	197	5	EFO_0001645, EFO_0004630
Disease	low density lipoprotein cholesterol measurement, physical activity	TDRD15 APOB RP1 DNAH11	1.01e-03	66	197	4	EFO_0003940, EFO_0004611
Disease	neuroblastoma	TDRD15 TRIO KALRN RGS5 L1TD1	1.11e-03	116	197	5	EFO_0000621
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 APOB	1.21e-03	8	197	2	EFO_0008589, EFO_0008595
Disease	aspergillosis (is_implicated_in)	TLR6 TLR1	1.21e-03	8	197	2	DOID:13564 (is_implicated_in)
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13C GEMIN5	1.21e-03	8	197	2	DOID:0050753 (implicated_via_orthology)
Disease	vitamin D-dependent rickets (implicated_via_orthology)	PF4 PPBP	1.21e-03	8	197	2	DOID:0080883 (implicated_via_orthology)
Disease	Familial hypercholesterolemia	APOA2 APOB	1.21e-03	8	197	2	cv:C0020445
Disease	Cardiovascular Diseases	VWF APOB CBS	1.78e-03	36	197	3	C0007222
Disease	Hypertensive disease	ADD1 VWF RGS5 PPBP CBS CCN2	1.79e-03	190	197	6	C0020538
Disease	Essential hypertension	ADD1 RGS5	1.93e-03	10	197	2	cv:C0085580
Disease	Essential hypertension, genetic	ADD1 RGS5	1.93e-03	10	197	2	cv:CN305331
Disease	HYPERTENSION, ESSENTIAL	ADD1 RGS5	1.93e-03	10	197	2	145500
Disease	sex interaction measurement, Crohn's disease	MAPKAPK2 LRRK2 PRORP	1.93e-03	37	197	3	EFO_0000384, EFO_0008343
Disease	Parkinson disease, disease progression measurement	ZNF106 SNCAIP AACS	2.24e-03	39	197	3	EFO_0008336, MONDO_0005180
Disease	gastrin-releasing peptide measurement	PF4 PPBP	2.34e-03	11	197	2	EFO_0022000
Disease	motor function measurement	IQSEC1 LRRC1	2.34e-03	11	197	2	EFO_0010749
Disease	Pancreatic Ductal Adenocarcinoma	ABCD2 EPHA3	2.34e-03	11	197	2	C1335302
Disease	colon cancer (implicated_via_orthology)	ATR CBS	2.34e-03	11	197	2	DOID:219 (implicated_via_orthology)
Disease	kidney cancer (implicated_via_orthology)	LLGL2 LRRC1	2.34e-03	11	197	2	DOID:263 (implicated_via_orthology)
Disease	myocardial infarction	TDRD15 PLCL2 PLCB2 PLCG2 SASH1 KALRN DYNC2H1 APOB	2.54e-03	350	197	8	EFO_0000612
Disease	response to anticonvulsant	TDRD15 C6orf118 ANK2 SASH1	2.56e-03	85	197	4	GO_0036277
Disease	prostate carcinoma	HGF TRIO MYO9B NOL10 SPDL1 LARP4B ANK2 CCDC88C SUGCT LMO7 COMMD7 CFAP44 KIF13A DNAH11	2.77e-03	891	197	14	EFO_0001663
Disease	Herpes Zoster, response to tofacitinib	VWF CACNA2D3	2.80e-03	12	197	2	EFO_0006510, EFO_0600024
Disease	Essential Hypertension	ADD1 RGS5	2.80e-03	12	197	2	C0085580
Disease	anti-Epstein Barr virus antibody measurement	MED12L SUGCT	2.80e-03	12	197	2	EFO_0009273
Disease	acute myeloid leukemia (implicated_via_orthology)	ARID4A TOP2A	2.80e-03	12	197	2	DOID:9119 (implicated_via_orthology)
Disease	stroke	ANK2 KALRN ZNF106 NDUFAF4 MICAL2	2.87e-03	144	197	5	EFO_0000712
Disease	Crohn's disease	MAPKAPK2 LRRK2 CHD6 ANK2 KALRN SBNO2 BRD2 POFUT1 PRORP	2.98e-03	441	197	9	EFO_0000384
Disease	C-reactive protein measurement	TDRD15 CCDC60 VPS13C CCDC168 NTM APOB CEP192 IFI16 ZNF106 SBNO1 SLC4A1AP AACS PRORP FYB1 FAM177A1 EPHA3 DNAH11	3.11e-03	1206	197	17	EFO_0004458
Disease	retinol dehydrogenase 16 measurement	PF4 PPBP	3.30e-03	13	197	2	EFO_0802007
Disease	Hyperlipoproteinemia Type IIb	APOA2 APOB	3.30e-03	13	197	2	C1704417
Disease	obesity (implicated_via_orthology)	GORASP1 MED12L PLCB2 GNL3 GNL3L DNAH10	3.32e-03	215	197	6	DOID:9970 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	TRIO NEXMIF ANK2 CACNA2D3	3.54e-03	93	197	4	C1535926
Disease	Thrombus	HGF PF4 VWF	3.60e-03	46	197	3	C0087086
Disease	cardiac troponin T measurement	TRIO NOL10 NTM SUGCT TMEM131 KIF13A	3.63e-03	219	197	6	EFO_0005043
Disease	atrial fibrillation (is_implicated_in)	VWF ANK2	3.83e-03	14	197	2	DOID:0060224 (is_implicated_in)
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 APOB	3.83e-03	14	197	2	EFO_0004611, EFO_0008589
Disease	Neuroblastoma	HGF CHD6 TOP2A	3.83e-03	47	197	3	C0027819
Disease	Adenocarcinoma of large intestine	CDK12 MDM2 NRK MLH3	3.97e-03	96	197	4	C1319315
Disease	Thrombosis	HGF PF4 VWF	4.31e-03	49	197	3	C0040053
Disease	low density lipoprotein triglyceride measurement	TDRD15 APOB	4.40e-03	15	197	2	EFO_0009946
Disease	acute graft vs. host disease, donor genotype effect measurement	KALRN TMEM131	4.40e-03	15	197	2	EFO_0004599, EFO_0007892
Disease	response to statin, LDL cholesterol change measurement	TDRD15 APOB	4.40e-03	15	197	2	EFO_0007804, GO_0036273
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	TDRD15 APOB RP1 DNAH11	4.43e-03	99	197	4	EFO_0004611, EFO_0007878
Disease	diet measurement	SECISBP2L TDRD15 TRIO FAM186B PLEKHM1 NTM CHD6 PLCG2 NIPBL DPY19L2P1 OR4K17 APOB PTPN21 COMMD7 EXOC4	4.74e-03	1049	197	15	EFO_0008111
Disease	obesity (is_marker_for)	HGF VWF APOA2 APOB	4.75e-03	101	197	4	DOID:9970 (is_marker_for)
Disease	response to trauma exposure	PHTF2 TET1 DNAH11	4.82e-03	51	197	3	EFO_0008483
Disease	free cholesterol to total lipids in small HDL percentage	TDRD15 APOA2 APOB	4.82e-03	51	197	3	EFO_0022285
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	TDRD15 APOB RP1 DNAH11	4.92e-03	102	197	4	EFO_0004329, EFO_0004611
Disease	Hyperlipoproteinemia Type IIa	APOA2 APOB	5.00e-03	16	197	2	C0745103
Disease	Barrett Epithelium	HGF SLC9A1	5.00e-03	16	197	2	C1258085
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	TRIO VWF	5.00e-03	16	197	2	EFO_0004569, MONDO_0009354
Disease	Abnormal behavior	MED12L IQSEC1	5.00e-03	16	197	2	C0233514
Disease	Barrett Esophagus	HGF SLC9A1	5.00e-03	16	197	2	C0004763
Disease	ceramide measurement	CDK12 PLCG2 APOB ZNF106 SNCAIP MICAL2	5.10e-03	235	197	6	EFO_0010222
Disease	systemic scleroderma (is_marker_for)	HGF PF4 VWF	5.37e-03	53	197	3	DOID:418 (is_marker_for)
Disease	Heschl's gyrus morphology measurement	MED12L KALRN ZNF804B	5.37e-03	53	197	3	EFO_0005852
Disease	serum selenium measurement	CBS AACS KIF13A	5.37e-03	53	197	3	EFO_0005266
Disease	Muscle hypotonia	ABAT NSD2	5.65e-03	17	197	2	C0026827
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 APOB	5.65e-03	17	197	2	EFO_0022232
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR6 TLR1	5.65e-03	17	197	2	DOID:8677 (biomarker_via_orthology)
Disease	triglycerides in medium VLDL measurement	TDRD15 DNAH10 APOB	5.96e-03	55	197	3	EFO_0022155
Disease	growth-regulated alpha protein measurement	PF4 PPBP CFAP44	5.96e-03	55	197	3	EFO_0008146
Disease	free cholesterol to total lipids in large HDL percentage	TDRD15 APOA2 APOB	6.27e-03	56	197	3	EFO_0022279
Disease	syndrome (implicated_via_orthology)	DONSON NSD2	6.32e-03	18	197	2	DOID:225 (implicated_via_orthology)
Disease	essential hypertension (is_implicated_in)	ADD1 RGS5	6.32e-03	18	197	2	DOID:10825 (is_implicated_in)
Disease	C-C motif chemokine 3 measurement	PLCG2 TLR1	6.32e-03	18	197	2	EFO_0008051
Disease	Tourette syndrome, schizophrenia	DNAH10 PHF3	6.32e-03	18	197	2	EFO_0004895, MONDO_0005090
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 APOB	6.32e-03	18	197	2	EFO_0008317, EFO_0008589
Disease	Hypercholesterolemia, Familial	APOA2 APOB	6.32e-03	18	197	2	C0020445
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	PLCG2 SMARCAL1 DNM3 FYB1	6.42e-03	110	197	4	EFO_0003095, MONDO_0005148

Protein segments in the cluster

Peptide	Gene	Start	Entry
NIKDPKGVKIIKELA	SUGCT	116	Q9HAC7
LQKTVKKLPAGIKRK	ABCA5	1426	Q8WWZ7
PEALKKGPLLIKKVA	ESYT3	596	A0FGR9
GLESKKLPRSVKLEK	CDK12	441	Q9NYV4
ELLLGRKNTPKQKEK	ARID4A	516	P29374
KEKKLKRKILGQSSP	ARID4A	851	P29374
EKSKEQLTPLIKKAG	APOA2	66	P02652
KVKPDSKVFLLLQKL	CDK19	301	Q9BWU1
TAVLILGPKVIKEKL	BPIFB1	26	Q8TDL5
LGPKVIKEKLTQELK	BPIFB1	31	Q8TDL5
GLDGKIVKSIVEKKP	ABCD2	126	Q9UBJ2
RKLFPIKLKNKKGLV	TBC1D32	446	Q96NH3
LPATKLVKLKDRKVQ	ADAM28	186	Q9UKQ2
EKLQQVVKGLPDLKK	AACS	221	Q86V21
EQKIILGKGKSRPKL	ARGLU1	251	Q9NWB6
LPDVKVAGLVKITLK	SPATA5	586	Q8NB90
PGKNRDLKVVKKNIL	CORO1C	396	Q9ULV4
ALQKILEKPLEKKAG	DNAH11	2546	Q96DT5
LELKSSIIGKKKPAA	ARFGAP2	206	Q8N6H7
IKEGILKIKEEPSKI	ARAP2	1436	Q8WZ64
LKIKEEPSKILSGNK	ARAP2	1441	Q8WZ64
AGKPILILANKQDKK	ARL13A	121	Q5H913
PKGKKRFILLEKIAS	FAM186B	71	Q8IYM0
VGLQKIPKVSEKTKL	CHAD	41	O15335
TGPTKKKVKELRILD	DIAPH2	696	O60879
KKVKELRILDPKTAQ	DIAPH2	701	O60879
LLKKIKEAIGKIPAA	CCDC14	856	Q49A88
KGKKFRPKTLSEIIV	CFAP44	1101	Q96MT7
NLLPKLHVVKIVAKK	CLIC5	346	Q9NZA1
LKEAILKKKIGKPEI	DPP10	521	Q8N608
LKKKIGKPEIKILHI	DPP10	526	Q8N608
PAKKILVKLQKFGEN	CCDC60	471	Q8IWA6
TKVTKPLLLKNGKTA	CPNE6	121	O95741
KRKAPTLTLLKGFKI	RASL12	251	Q9NYN1
PKKELINIKGISEAK	RAD51	56	Q06609
AIKKTILDKVKLDSP	PYCR1	281	P32322
TPIGSIKDKVKALQK	ANK2	1761	Q01484
PNLKKRKGLELKVVA	DPY19L2P1	56	Q6NXN4
KQLLKDKPEHVGVKV	ISCA1	36	Q9BUE6
QIEGLKLLQKTRKPK	LONP2	221	Q86WA8
LSILAKKVPILSKKE	MED12L	126	Q86YW9
KIKKIEDASNPLLLK	MAPKAPK2	371	P49137
VFTLPKVSAKLKLKL	LLGL2	821	Q6P1M3
VLKSKFLPTLEQKLK	NGRN	121	Q9NPE2
NVELGVIGKKKKVPR	FAM177A1	41	Q8N128
KKGVKVENRPFLSKL	NTM	266	Q9P121
KAPKLEERLKVLTNK	GLRX3	231	O76003
PFKLKLHGIAKVLVK	KY	596	Q8NBH2
DLKIVPLGRKEAKAK	LRRC47	396	Q8N1G4
QVQKVEKLIVGKKPI	IQSEC1	721	Q6DN90
RKKKKTVAGIIVEPI	ABAT	281	P80404
GKPIKARIKAKAIAI	LARP4B	301	Q92615
IGAKALVKLIKPKKE	CCDC88C	1406	Q9P219
LPLESKDVVKKVQKL	FSIP2	5976	Q5CZC0
AIVKKQIVKLKGPSL	DNM3	411	Q9UQ16
QIVKLKGPSLKSVDL	DNM3	416	Q9UQ16
DKLIGFSKPIVRKKL	MLH3	731	Q9UHC1
TPKVILNLLKKQKVI	OR4K17	81	Q8NGC6
EKIKLLKPISGKLRA	NSD2	306	O96028
KEQEIKKKFKLTGPI	FYB1	496	O15117
TQLKKKVLKAPVEEL	KALRN	231	O60229
RKPKDILGNKVSVKE	KALRN	2426	O60229
GALKNFVIPKIKRDK	NIPBL	951	Q6KC79
IIKSNPDLQKKIKVL	KLHL41	241	O60662
VSISKLPKLKKLNIK	LRRC18	161	Q8N456
INKLKPGVIKKINRL	LMO7	101	Q8WWI1
EDKTVKLKGAAPLKI	LRRK2	2276	Q5S007
LAPRSKVKKIIQKDI	LARP7	306	Q4G0J3
LLHEVPIEGQKKKRK	KRIT1	36	O00522
PIEGQKKKRKKVLLE	KRIT1	41	O00522
AKTTLIKIDPALKIK	HGF	46	P14210
IKIDPALKIKTKKVN	HGF	51	P14210
QLREKIIIKHKKLGP	PLCG2	446	P16885
VQLKKLPKVNKELAL	NOL10	441	Q9BSC4
KALLKANVEKPVKLE	GORASP1	56	Q9BQQ3
LLTLPKSIGKLKKLS	LRRC1	301	Q9BTT6
TLGVQRPKLEKKDAK	MYBBP1A	1141	Q9BQG0
KPQLKLKIKLGGQVL	INO80B	66	Q9C086
KTRVDAKKIGPLKLA	PTPN21	841	Q16825
ILSCGELIPKSKVKK	PPIG	171	Q13427
VLLVTKPQRKADKAK	PLEKHG6	436	Q3KR16
FKALKIKGKEVERLP	DYNC2H1	886	Q8NCM8
IPVFEQKKPLAKKVL	EBLN1	261	P0CF75
ILIKGLAKLKKIPET	EXOC4	281	Q96A65
LAKLKKIPETVKAII	EXOC4	286	Q96A65
LKKLVKEALKESQLP	APOB	611	P04114
EILASLQKPKKISLK	ATR	2301	Q13535
VPVKDKKLLEVKLGE	ATP5MF	11	P56134
KKKGRKIPKLEELLS	TTC26	21	A0AVF1
KVQALKKSKLLLPIT	CCDC106	261	Q9BWC9
NEINLLSGKIKKKIP	CPLANE1	41	Q9H799
VKELLKTIPKYKLGI	CACNA2D3	506	Q8IZS8
GKKTKNQLLIPELKD	CHD6	1186	Q8TD26
LLESGKSELKKQVKP	CD1D	191	P15813
LEENIKKGKKCIRTP	CCN2	246	P29279
SGKKEVPVAIKTLKA	EPHA2	636	P29317
LKKTIDRKSPLILKG	CMYA5	711	Q8N3K9
KKGVKPKLVLNVTSE	CMYA5	1251	Q8N3K9
VAKIVAPKKIKLAAA	DNAH7	2806	Q8WXX0
VDPVLGLVKVKKKLD	FAT3	3391	Q8TDW7
KLKVANKIESIPVKG	PYHIN1	86	Q6K0P9
AKSPKILPDILKKIG	CBS	71	P35520
ILKKKIKGPLEIYQG	C6orf118	446	Q5T5N4
IVKSLLLVPNGALKK	COMMD7	71	Q86VX2
KLPSKKEISVAIKTL	EPHA3	641	P29320
LKDIRKIFPGKKSVV	ALOX12B	236	O75342
TLKKEKLKVKGPALS	IFI16	81	Q16666
KDSQKKVLLDPKVLR	CEP192	1931	Q8TEP8
ERKKQLKKEGKPTIV	DNAJC8	136	O75937
QDKIKKPDILSIKLR	DONSON	371	Q9NYP3
KKLVLILNKSDLVPK	GNL3	171	Q9BVP2
ALQEVLKKLKSKRVP	CARTPT	56	Q16568
DVLQIKSPKVKKALK	CCDC168	3276	Q8NDH2
GISRKEPLLKLENKK	ERCC6L2	1421	Q5T890
PSAKGKKNQIGLKIL	CYLD	61	Q9NQC7
AKAVTKVIPELKGKL	GAPDHS	286	O14556
PLTKKEKKVLQKILE	DHX37	71	Q8IY37
EKGCLIKSKPKVLVV	DNAH10	4391	Q8IVF4
LEATGQLPVKKGKAK	GFM1	736	Q96RP9
FILPVNEGKKLKEKL	SBDS	176	Q9Y3A5
KKLKVNSLPEILKEV	SACS	4296	Q9NZJ4
KTAILVKEVNPKKKL	SBNO1	1216	A3KN83
PRIKKIVQKKLAGDE	PPBP	111	P02775
APIKKQKKRVAELAL	CMTR1	11	Q8N1G2
PVLVKEKLGLKKLVL	MICAL2	1431	O94851
LKQLKAIVTEPKTEK	KIF23	651	Q02241
QCGLTKLPKNEKKIL	RP1	651	P56715
QLFKGKVKVVSLKPE	POFUT1	321	Q9H488
EKGLVKDKIIVVPLK	KIF13A	1656	Q9H1H9
TGIIKKRQKKGIPLI	NRK	331	Q7Z2Y5
KLKNILKPGCLQDTK	GARIN2	306	Q8N9W8
IVALPKIILAVKSKG	RNFT2	281	Q96EX2
PVIKKKLVGSVKALQ	PLEKHM1	16	Q9Y4G2
VEKIQAKLPGIAKKK	RTN3	1016	O95197
NGEVKILLKSGKEKP	RSBN1L	226	Q6PCB5
ILLKSGKEKPKTNIE	RSBN1L	231	Q6PCB5
APKKRQIKLLKEADV	FAM47E	86	Q6ZV65
LQEKLLLKTEKKVGP	AK9	1026	Q5TCS8
LKPIAKLFSVIKNKL	UTP20	1391	O75691
EIKFIKLGLRNKPKK	PHTF2	66	Q8N3S3
LAIPVVKGRKTEKEK	EPRS1	1201	P07814
KKRKGNLPAESVKIL	TGIF2LX	51	Q8IUE1
KKRKGNLPAESVKIL	TGIF2LY	51	Q8IUE0
KCLPKDILVKFQGIK	TDRD15	21	B5MCY1
LNKKGILKVGFPIKT	TDRD15	461	B5MCY1
PVDKLKGVSLIKVKF	MRM3	156	Q9HC36
AKEIKIKLGILLQKP	RGS5	16	O15539
KKEREGPKLVKLLTG	SAMD9	386	Q5K651
TLKILAGTPQESKKK	NEXMIF	1366	Q5QGS0
KKLVLVLNKIDLVPK	GNL3L	166	Q9NVN8
PGLKTSKIELKFKEL	PLCL2	301	Q9UPR0
KPLLLKLLKSVGAQK	MDM2	31	Q00987
LLSKLEKQLKTPFKV	SMARCAL1	531	Q9NZC9
LKKEKKCVKLIGVPA	SPDL1	526	Q96EA4
NSKKIPLEKRELKLA	SNCAIP	651	Q9Y6H5
LKTKDRKKQVGIKIP	SBNO2	1196	Q9Y2G9
GKEKEIAKLKRPTAL	SECISBP2L	561	Q93073
IKSIPKGKISIVEAL	NDUFAF4	106	Q9P032
LLLEDIKKVITPSKK	PRORP	231	O15091
KKLDSKVNIIPIIAK	SEPTIN6	171	Q14141
LLGVTLLKKKYPLAK	SLC35B1	126	P78383
KIKSIPKQVVKLEAL	TLR1	456	Q15399
SLLVIETKKPPLKKG	U2SURP	181	O15042
VKTLSPGKLKQLIQE	TET1	41	Q8NFU7
PGKLKQLIQERDVKK	TET1	46	Q8NFU7
VVAKSKKVPLSKGLE	TET1	121	Q8NFU7
TIKKPVGKTKEELAL	BRD2	716	P25440
VDIKGPKLDLKVSKA	AHNAK2	3741	Q8IVF2
KLGVPKTHLELKKLI	AIF1	76	P55008
EEKVLIQKNLGPKSK	ADD1	281	P35611
GKSILKITKVKFAPI	CILP	271	O75339
IDKLPKERTKLSVGK	C12orf71	116	A8MTZ7
ALKDEKLQGLKTKQP	C11orf91	171	Q3C1V1
KPQKIEIRKDTLKAL	ERVK-25	251	P63136
TKKKKLIAAVVLGIL	TMTC4	436	Q5T4D3
KKKTEGLVKLTPIDK	TRIM24	891	O15164
TKKVDLFKKSLLLIP	SENP5	626	Q96HI0
LGKKPLELKTKRESQ	ZNF804B	501	A4D1E1
KTTLVGIIKVDPKQL	WASHC5	691	Q12768
VQGLKKKKVIVIPVG	VWF	1401	P04275
PNAKIKELKGEKVIR	REV1	96	Q9UBZ9
TLKKGKVKSIDLPIQ	HSPA4L	571	O95757
EAVILPKDLKSGKQK	REXO5	626	Q96IC2
PIKVVEGVKELSKKL	POLR2A	1006	P24928
LNLILKPGEKKSVKV	TMEM131	926	Q92545
SKKLLNIKKEIPTDV	TMEM131	1466	Q92545
PQGKKSIELEKKRLS	GEMIN5	721	Q8TEQ6
IKKKSDGPDNIIKRI	PIEZO2	1631	Q9H5I5
KLKAKIISKGLPVRF	TTC41P	216	Q6P2S7
DELQKRVPKLIFKKG	ZNF281	456	Q9Y2X9
PKNNILFKKVLKGEV	PHF3	991	Q92576
KLKKGDIIDIISKPP	SASH1	576	O94885
PLVDLLAVKKKQETK	SLC9A1	501	P19634
KVKAGQIDKLTLKIP	VPS13C	56	Q709C8
VKVPFLKKCKEAGLL	PHF11	216	Q9UIL8
LQAPLYKKIIKKLLE	PF4	86	P02776
PEDLRGKILIKNKKN	PLCB2	451	Q00722
LLIKDQKKIPIKRAD	NSMCE3	96	Q96MG7
KIKSVPKQVVKLEAL	TLR6	461	Q9Y2C9
LEKIDGKIIIENKPK	TOP2A	1056	P11388
GKIIIENKPKKELIK	TOP2A	1061	P11388
KFKKLLVPGKIQHIL	VPS29	21	Q9UBQ0
KIKVIEGSLQPIIKT	POSTN	681	Q15063
PDLLIKVLGILKKNV	TUT4	426	Q5TAX3
SIIIGKSKLPKSVKE	TIGD7	226	Q6NT04
KVIPTLALLKDGKTQ	TXNDC9	141	O14530
ILKKGKKVIFLEPGN	WDR87	1366	Q6ZQQ6
LSKEPAKLNKILKAL	WDR87	2066	Q6ZQQ6
QKLTLPGDKNRLKKV	ZFC3H1	306	O60293
RLKKVKDGAKPLSLK	ZFC3H1	316	O60293
VLTVKPVRKVKAGKL	ZNF106	1376	Q9H2Y7
SQLKKKVIKAPIEDL	TRIO	261	O75962
LVVKEDQKIPTGKKL	ZNF34	236	Q8IZ26
ELKLEKKIKIRVEPG	UBASH3A	496	P57075
GTPTIKSKKKLLQII	VPS39	446	Q96JC1
KKLALAGIGQPVKKS	TPX2	236	Q9ULW0
KSSVKELLKDVLPQK	L1TD1	306	Q5T7N2
KVLKSPKCKLQVLGL	NLRP14	1036	Q86W24
KKNGQKAAVKILDPI	MYO3A	41	Q8NEV4
LAKKQLKGKNPEDLI	MMUT	46	P22033
KEQQRLKGLIKIVKP	SLC4A1AP	566	Q9BWU0
FILKSKGIKQKQIIP	MYO9B	776	Q13459
KGIKQKQIIPKNLLD	MYO9B	781	Q13459
LAKPTVIISKKGDII	PMP2	36	P02689